| Low molecular weight, non-polymeric compounds produced via either total synthesis or semi-synthetic processes.
|
|
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
| Ligand name |
Abbreviated name |
Synonyms |
| A |
Back to top |
|
A-119637
|
|
|
|
A-123189
|
|
|
|
A127722
|
|
A 127722,
A-127722,
trans-trans-2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-([N,N-dibutylamino]carbonylmethyl)pyrrolidine-3-carboxylate
|
|
A134974
|
|
A 134974,
A-134974,
N7-[(1′R,2′S,3′ R,4′S)-2′,3′-dihydroxy-4′-aminocyclopentyl]-4-amino-5-iodopyrrolopyrimidine
|
|
A192621
|
|
(2R,3R,4S)-2-(4-propoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(N-[2,6-diethylphenyl]acetamido)pyrrolidine-3-carboxylic acid
|
|
A-304121
|
|
4-(3-((2R)-2-aminopropanoyl-1-piperazinyl)propoxy)phenyl)cyclopropylmethanone
|
|
A317491
|
|
5-({[3-phenoxybenzyl][(1S)-1,2,3,4-tetrahydro-1-naphthalenyl]amino}carbonyl)-1,2,4-benzenetricarboxylic acid
|
|
A317567
|
|
A-317567,
C-{6-[2-(1-Isopropyl-2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-yl)-cyclopropyl]-naphthalen-2-yl}-methanediamine
|
|
A-317920
|
|
N-((1R)-2-(4-(3-(4-(cyclopropylcarbonyl)phenoxy)propyl)-1-piperazinyl)-1-methyl-2-oxo-ethyl-)-2-furamide
|
|
A331440
|
|
A 331440,
A-331440
|
|
A-349821
|
|
(4′-(3-((R,R)2,5-dimethyl-pyrrolidin-1-yl)-propoxy)-biphenyl-4-yl)-morpholin-4-yl-methanone,
Aminoalkoxybiphenylcarboxamide class
|
|
A412997
|
|
A 412997,
A-412,997
|
|
A425619
|
|
1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)urea
|
|
A438079
|
|
3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl) methyl pyridine
|
|
A-582941
|
|
2-methyl-5-(6-phenyl-pyridazin-3-yl)-octahydro-pyrrolo[3,4-c]pyrrole
|
|
A61603
|
|
N-[1-(4,5-dihydro-1H-imidazol-2-yl)-6-hydroxy-tetralin-5-yl]methanesulfonamide,
N-[5-(4,5-dihydro-1H-imidazol-2yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl] methanesulphonamide hydrobromide
|
|
A-674563
|
|
A 674563
|
|
A740003
|
|
(N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide
|
|
A778317
|
|
1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea
|
|
A-803467
|
|
A 803467
|
|
A804598
|
|
(s)-1-(1-(4-bromophenyl)ethyl)-2-cyano-3-(quinoline-5-yl)guanidine
|
|
A839977
|
|
1-(2,3-dichlorophenyl)-N-[2-(pyridin-2-yloxy)benzyl]-1H-tetrazol-5-amine
|
|
A841720
|
|
|
|
A-85380
|
|
A 85380
|
|
A-867744
|
|
4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide
|
[3H]A317491
|
|
[3H]A 317491,
[3H]A-317491
|
[3H]A-585539
|
|
(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azaniabicyclo[2.2.1]heptane
|
[3H]A778317
|
|
|
[3H]A804598
|
|
[3H]A 804598
|
[3H]A81988
|
|
[3H]-A81988
|
|
Abbott 14c
|
|
2,4-diaminopyrimidine-based antagonist, 14c,
SureCN6403056,
urea, N-[4-[2,4-diamino-6-[(phenylmethoxy)methyl]-5-pyrimidinyl]phenyl]-N'-(1,1-dimethylethyl)-
|
|
AB-MECA
|
|
5-[6-[(4-aminophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyl-oxolane-2-carboxamide,
N(6)-4-aminobenzyladenosine-5'-N-methyluronamide,
N6-(4-aminobenzyl)-adenosine-5'-N-methyluronamide
|
[125I]AB-MECA
|
|
[125I]5-[6-[(4-aminophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyl-oxolane-2-carboxamide,
[125I]-AB-MECA,
[125I]N(6)-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide
|
|
AB-NECA
|
|
aminobenzyl-5'-N-ethylcarboxamidoadenosine
|
|
abnormal cannabidiol
|
|
Abn-CBD,
CAY10429
|
[125I]ABOPX
|
|
[125I]3-(3,4-aminobenzyl)-8-(4-oxyacetate)phenyl-1-propyl-xanthine
|
|
ABT-229
|
|
8,9-anhydro-4′′-deoxy-3′-N-desmethyl-3′-N-ethylerythromycin B 6,9-hemiacetal,
ABT229,
Alemcinal,
N-ethyl,N-methyl 4'' deoxy EM-B enolether
|
|
ABT-239
|
|
4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile
|
|
ABT-299
|
|
(R)-1-acetoxymethyl-3-{-[1-(N,N-dimethylcarbamoyl)-6-(4-fluoro-phenyl)-indol-3-oyl]- 1H,3H-pyrrolo[1,2-c]thiazol-3-yl }pyridinium chloride
|
|
ABT-491
|
|
4-ethynyl-N,N-dimethyl-3-[3-fluoro-4-[(2-methyl-1H-imidazo-[4,5-c]pyridin-1-yl)methyl]benzoyl]-1H-indole-1-carboxamide hydrochloride
|
|
ABT702
|
|
4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2,3-d]pyrimidine,
ABT 702,
ABT-702
|
|
9-A-C
|
|
9-AC,
9-anthracenecarboxylic acid,
9-Anthroic acid,
9-carboxyanthracene,
A9C,
ANCA,
anthracene-10-carboxylic acid,
anthracene-9-carboxylic acid,
NSC 151909
|
|
AC-260584
|
|
4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one
|
|
AC261066
|
|
|
|
AC262620
|
|
AC-262620
|
|
AC262970
|
|
AC-262970
|
|
AC263093
|
|
|
|
AC265347
|
|
AC-265347
|
|
AC-42
|
|
4-(4-butyl-1-piperidyl)-1-(o-tolyl)butan-1-one,
4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine
|
|
AC45594
|
|
4-heptoxyphenol,
4-(Heptyloxy)benzolol,
4-(Heptyloxy)phenol
|
|
AC55649
|
|
|
|
AC-7954
|
|
3-(4-chlorophenyl)-3-(2-dimethyl-aminoethyl)-isochroman-1-one HCl,
3-(4-chlorophenyl)-3-(2-(dimethylamino)ethyl)isochroman-1-one hydrochloride,
AC7954,
racemic-3-(4-Chlorophenyl)-3-(2-(dimethylamino)ethyl)isochroman-1-one hydrochloride
|
|
AC-90179
|
|
2-(4-methoxy-phenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide hydrochloride
|
|
ACAA
|
|
ACA
|
|
ACDPP
|
|
|
|
(-)aceclidine
|
|
R-(-)-aceclidine
|
|
(+)aceclidine
|
|
S-(+)-aceclidine
|
|
ACET
|
|
(S)-1-(2-amino-2-carboxyethyl)-3-(2-carboxy-5-phenylthiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione
|
|
acetamide
|
|
ethanamide,
methylformamide
|
|
acetoacetic acid
|
|
acetoacetate,
diacetic acid
|
|
acetyl-podocarpic dimer
|
|
acetyl Podocarpic acid anhydride,
ADP
|
|
acifran
|
|
5-methyl-4-oxo-5-phenylfuran-2-carboxylic acid,
AY 25712,
D02753,
reductol
|
|
acipimox
|
|
6-methyl-1-oxidopyrazin-1-ium-2-carboxylic acid
|
[35S]ACPPB
|
|
[35S]-ACPPB ,
[35S]-(S)-2-amino-4-chloro-N-(1-(4-phenyl-1-(propylsulfonyl)piperidin-4-yl)ethyl)benzamide
|
|
ACPT-I
|
|
1-aminocyclopentane-1,3,4-tricarboxylic acid
|
|
acrolein
|
|
|
|
acrylamide
|
|
|
|
ACT-078573
|
|
Almorexant
|
|
active metabolite of clopidogrel
|
|
(2Z)-2-[1-[(S)-(2-chlorophenyl)-methoxycarbonyl-methyl]-4-sulfanyl-3-piperidylidene]acetic Acid
|
|
acyclovir
|
|
Aciclovir
|
|
AD-5061
|
|
|
|
AD5075
|
|
|
[3H]AD5075
|
|
[3H]-AD5075
|
|
adapalene
|
|
|
|
adenophostin A
|
|
|
[35S]ADPβS
|
|
|
|
(+)-ADTN
|
|
6-amino-5,6,7,8-tetrahydronaphthalene-2,3-diolaminotetralin-6,7-diol,
(+)-ADTN (aminotetralin-6,7-diol)
|
|
ADX-47273
|
|
(S)-(4-fluorophenyl)-(3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]piperidin-1-yl)methanone
|
|
AF353
|
|
(5-(5-iodo-2-isopropyl-4-methoxy-phenoxy)-pyrimidine-2,4-diamine
|
|
afatinib
|
|
BIBW 2992
|
|
AFD(R)
|
|
|
|
AF-DX 116
|
|
[[2-[(diethylamino)methyl]-1-piperidinyl]acetyll-5,ll-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepine-6-one,
AFDX116,
otenzepad
|
|
AFDX384
|
|
AF-DX 384,
AFDX-384
|
|
[3H]AF DX-384
|
|
(+-)-5,11-dihydro-11-([(2-(2-[(dipropylamino)methyl]-1-piperidinyl)ethyl)amino]carbonyl)-H-pyrido(2,3-b)(1,4)benzodiazepine-6-one,
[3H]5,11-Dihydro-11-(((2-(2-((dipropylamino)methyl)-1-piperidinyl)ethyl)amino)carbonyl)-6H-pyrido(2,3-b)(1,4)-benzodiazepin-6-one methanesulfonate,
[3H]AF-DX 384
|
|
AFP-07
|
|
18,19-didehydro-7,7-difluro-16S,20-dimethyl-PGI2,
(5Z)-5-[(1S,3R,4R,5R)-6,6-difluoro-3-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-8-oxabicyclo[3.3.0]oct-7-ylidene]pentanoic acid,
7,7-difluoro-16S,20-dimethyl-18,19-didehydro-PGI2,
AFP07
|
|
AG-09/1
|
|
AG-09/1 [benzimidazole derivative]
|
|
AG-11/03
|
|
AG-11/03 [benzimidazole derivative]
|
|
AG-14
|
|
1,3-benzodioxolane-5-carboxylic acid 4`-benzyloxy-3`-methoxy-benzylidene-hydrazide
|
|
AG1478
|
|
N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride,
tyrphostin AG1478
|
|
AG879
|
|
tyrphostin AG879
|
|
AGN192093
|
|
(Z)-7-([1α,5α,6α,7β]-7-[{1E,3S}-3-hydroxy-1-octenyl]-3-oxo-2,4-dioxobicyclo[3.2.1]oct-6-yl)-5-heptenol
|
|
AGN193109
|
|
4-[2-[5,5-dimethyl-8-(4-methylphenyl)-6H-naphthalen-2-yl]ethynyl]benzoic acid,
4-[2-(5,6-dihydro-5,5-dimethyl-8-p-tolylnaphthalen-2-yl)ethynyl]benzoic acid,
AGN 193109
|
|
AGN193836
|
|
|
|
AGN194204
|
|
|
|
AGN 211334
|
|
|
|
agomelatine
|
|
N-(2-[7-methoxy-1-naphthalenyl]ethyl)acetamide,
N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide,
S20098
|
|
AG-041R
|
|
2-[(3R)-1-(2,2-diethoxyethyl)-2-oxo-3-(p-tolylcarbamoylamino)indolin-3-yl]-N-(p-tolyl)acetamide,
[3R-1-(2,2-diethoxyethyl)-3-((4-methylphenyl)aminocarbonylmethyl)-3-((4-methylphenyl)ureido)-indoline-2-one
|
|
AH13205
|
|
7-[2-[4-(1-hydroxyhexyl)phenyl]-5-oxo-cyclopentyl]heptanoic acid,
AH 13205
|
|
AH23848
|
|
(1α[z],2β,5α)-(±)-7-(5-[{(1,1′-biphenyl)-4-yl}methoxy]-2-[4-morpholinyl]-3-oxocyclopentyl)-4-heptenoate,
(-)AH23848,
AH23848(-),
(Z)-7-[(1R,2R,5S)-2-morpholin-4-yl-3-oxo-5-[(4-phenylphenyl)methoxy]cyclopentyl]hept-4-enoic acid
|
|
AH6809
|
|
6-isopropoxy-9-oxoxanthene-2-carboxylic acid,
9-oxo-6-propan-2-yloxy-xanthene-2-carboxylic acid,
AH 6809,
AH-6809,
Tocris-0671
|
|
(S)-4-AHCP
|
|
(S)-2-amino-3-(3-hydroxy-7,8-dihydro-6(i>H-cyclohepta[d]isoxazol-4-yl)propionic acid
|
|
AHPN
|
|
CD437,
Ro 47-2077
|
|
AH23848 (racemic)
|
|
|
|
AICA-riboside
|
|
5-aminoimidazole-4-carboxamide-1-β-riboside,
acadesine
|
|
AIDA
|
|
1-amino-2,3-dihydroindene-1,5-dicarboxylic acid,
1-aminoindan-1,5-dicarboxylic acid,
1-aminoindan-1,5(RS)-dicarboxylic acid,
UPF523,
UPF 523
|
|
(+)-AJ76
|
|
(1S,2R)-5-methoxy-1-methyl-N-propyl-tetralin-2-amine,
cis-(+)-(1S,2R)-5-methoxy-l-methyl-2-(n-propylamino)tetralin)
|
|
AL12180
|
|
5,6-dihydro-4,5-didehydro-11-deoxy-11-oxa-16-(3-chlorophenoxy)-ω-tetranor-PGF2α
|
|
AL-8810
|
|
(5Z, 13E)-(9S, 11S,15R)-9,15-dihydroxy-11-fluoro-15-(2-indanyl)-16,17,18,19, 20-pentanor-5,13-prostadienoic acid,
(Z)-7-[(1R,2R,3S,5S)-3-fluoro-5-hydroxy-2-[(E,3R)-3-hydroxy-3-indan-2-yl-prop-1-enyl]cyclopentyl]hept-5-enoic acid
|
|
AL-37350A
|
|
(2S)-1-(3,7,8,9-tetrahydropyrano[3,2-e]indol-1-yl)propan-2-amine,
(S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole
|
|
alendronic acid
|
|
4-amino-1-hydroxybutylidene-1,1-bisphosphonate,
ABDP,
BPH 1
|
|
aliskiren
|
|
Rasilez
|
|
alkylbenzene sulfonate
|
|
|
|
alkyl OMPT
|
|
|
|
alloxazine
|
|
alloxazin,
isoalloxazine
|
|
all-trans-4-oxo-retinoic acid
|
|
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxo-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid,
4-oxoretinoic acid
|
|
1-allyl-2-[3-(benzylamino)propoxy]-9H-carbazole
|
|
3-[(1-allyl-9H-carbazol-2-yl)oxy]-N-(phenylmethyl)propan-1-amine,
3-[(1-allyl-9H-carbazol-2-yl)oxy]propyl-(benzyl)amine,
N-(phenylmethyl)-3-[(1-prop-2-enyl-9H-carbazol-2-yl)oxy]propan-1-amine
|
|
1-allyl-2-[3-(isopropylamino)propoxy]-9H-carbazole
|
|
|
|
1-allyl-2-[3-(isopropylamino)propoxy]-9H-xanthen-9-one
|
|
|
|
allyl isothiocyanate
|
|
|
|
alniditan
|
|
N'-(chroman-2-ylmethyl)-N-(1,4,5,6-tetrahydropyrimidin-2-yl)propane-1,3-diamine
|
[3H]alniditan
|
|
|
|
alosetron
|
|
GR68755
|
|
(3alpha,5beta,12alpha,17xi)-3-hydroxy-21-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]pregnan-12-yl (2S)-2-methylbutanoate
|
|
|
|
alphaxalone
|
|
3α-Hydroxy-5α-pregnane-11,20-dione,
5α-alphaxalone,
5α-Pregnane-3α-ol-11,20-dione,
alfadione,
alfaxalone
|
|
alprenolol
|
|
1-(o-Allylphenoxy)-3-(isopropylamino)-2-propanol,
1-propan-2-ylamino-3-(2-prop-2-enylphenoxy)-propan-2-ol,
Alfeprol,
Alpheprol,
Alprenololum
|
|
ALRT 1550
|
|
7-(3,5-DITERT-BUTYLPHENYL)-3-METHYLOCTA-2,4,6-TRIENOIC ACID
|
[18F]altanserin
|
|
[18F]altanserin (PET ligand)
|
|
alvocidib
|
|
HL 275,
HMR 1275,
L 868275,
L 86-8275
|
|
ALX 1393
|
|
O-[2-benzyloxyphenyl-3-flurophenyl]methyl-L-serine
|
|
ALX 1405
|
|
|
|
AM1241
|
|
(2-iodo-5-nitro-phenyl)-[1-(1-methyl-piperidin-2-ylmethyl)-1H-indol-3-yl]-methanone
|
|
AM251
|
|
N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide
|
|
AM281
|
|
1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-4-morpholinyl-1H-pyrazole-3-carboxamide,
1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-morpholin-4-ylpyrazole-3-carboxamide,
N-(morpholin-4-yl)-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxamide
|
|
AM630
|
|
[6-iodo-2-methyl-1-(2-morpholin-4-ylethyl)indol-3-yl]-(4-methoxyphenyl)methanone,
6-iodopravadoline
|
|
AM966
|
|
|
[123I]AM251
|
|
1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(1-piperidyl)pyrazole-3-carboxamide
|
|
AMA
|
|
S-(5'-deoxy-5'-adenosyl)-methylthioethyl-hydroxylamine
|
|
amantidine
|
|
|
|
4-AMBA
|
|
4-(aminomethyl)benzoic acid
|
|
ambrisentan
|
|
|
|
amesergide
|
|
LY237733,
N-Cyclohexyl-1-isopropyl-6-methylergoline-8β-carboxamide
|
|
AMG517
|
|
N-{4-[6-(4-trifluoromethyl-phenyl)-pyrimidin-4-yloxy]-benzothiazol-2-yl}-acetamide
|
|
AMG628
|
|
(R)-N-(4-(6-(4-(1-(4-fluorophenyl)ethyl)piperazin-1-yl)pyrimidin-4-yloxy)benzo[d]thiazol-2-yl)acetamide
|
|
AMG7703
|
|
|
|
AMI-193
|
|
8-[3-(4-fluorophenoxy)propyl]-1-phenyl-1,3,8-triazaspiro[4.5]-decan-4-one
|
|
amidephrine
|
|
N-[3-[1-hydroxy-2-(methylamino)ethyl]phenyl]methanesulfonamide
|
|
amiloride
|
|
|
|
aminobenzovesamicol
|
|
compound 11
|
|
2(S)-amino-6-boronohexanoic acid
|
|
ABH
|
|
2-amino-4-methylpyridine
|
|
|
[125I]aminopotentidine
|
|
1N-{2-[3-(3-hexahydro-1-pyridinylmethylphenoxy)propylamino(cyanoimino)methylamino]ethyl}-4-amino-3-iodobenzamide,
Iodoaminopotentidine,
[125I]APT,
[125I]-iodoaminopotentidine
|
|
4-aminopyridine
|
|
4-AP
|
|
5-aminosalicylate
|
|
5-aminosalicylic acid,
5-ASA
|
|
2-amino-3-sulfinopropanoic acid
|
|
3-sulfinoalanine,
cysteine sulfinate,
cysteine sulfinic acid,
cysteinesulphinate
|
|
amiodarone
|
|
|
|
amisulpride
|
|
4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide,
Amitrex,
(±)-amisulpride,
Solian,
Sulpitac,
sultopride
|
|
amitriptyline
|
|
amitryptiline,
amitryptyline,
Damilen,
Damitriptyline,
Elavil,
Flavyl,
Lantron,
Lentizol,
Proheptadiene,
Seroten,
Triptanol
|
|
ammonium carbonate
|
|
|
|
AMMTC
|
|
N-acetyl-4-aminomethyl-6-methoxy-9-methyl-1,2,3,4-tetrahydrocarbazole
|
|
AMN082
|
|
AMN 082,
N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride,
N,N'-bis(diphenylmethyl)-1,2-ethanediamine dihydrochloride,
N,N'-dibenzhydrylethane-1,2-diamine
|
|
amoxapine
|
|
amoxepine,
amoxipine
|
|
AMPA
|
|
(RS)-a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
|
[3H]AMPA
|
|
(RS)-α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
|
|
amphetamine
|
|
DL-amphetamine,
(±)-amphetamine
|
|
AMTB
|
|
N-(3-aminopropyl)-2-{[(3-methylphenyl) methyl]oxy}-N-(2-thienylmethyl)benzamide
|
|
amthamine
|
|
|
|
analogue26_3,5-diphenyl-1,2,4-oxadiazole
|
|
1,2,4-oxadiazole_based compound 26
|
|
anastrazole
|
|
arimidex
|
|
anatibant
|
|
LF160687,
LF 16-0687
|
|
ancriviroc
|
|
4-((4-bromophenyl)-(ethoxyimino)methyl)-1'-((2,4-dimethyl-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine-N-oxide,
Sch-351125,
SCH 351125,
SCH C,
SCH-C
|
[3H]ancriviroc
|
|
[4-[4-[C-(4-bromophenyl)-N-ethoxy-carbonimidoyl]-1-piperidyl]-4-m ethyl-1-piperidyl]-(2,4-dimethyl-1-oxido-pyridin-1-ium-3-yl)methanone,
[3H]4-((4-bromophenyl)-(ethoxyimino)methyl)-1'-((2,4-dimethyl-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine-N-oxide,
[3H]Sch-351125,
[3H]SCH 351125,
[3H]SCH-C
|
|
androstanol
|
|
5α-androstan-3α-ol
|
|
4,9-anhydro-tetrodotoxin
|
|
4,9-ah-TTX,
4,9-anhydro-TTX
|
|
aniracetam
|
|
|
|
antalarmin
|
|
N-butyl-N-ethyl-(2,5,6-trimethyl)-7-[2,4,6-trimethylphenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl-amine
|
|
AP18
|
|
4-(4-chlorophenyl)-3-methyl-3-buten-2-one oxime
|
[3H]AP4
|
|
[3H]2-amino-4-phosphonobutiric acid
|
|
Ap3a
|
|
diadenosine triphosphate
|
|
Ap5a
|
|
diadenosine pentaphosphate
|
|
APA
|
|
1-aminooxy-3-aminopropane
|
|
apadenoson
|
|
4-{3-[6-amino-9-(5-ethylcarbamoyl-3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-cyclohexanecarboxylic acid methyl ester,
ATL-146e
|
|
apafant
|
|
WEB 2086
|
[3H]apafant
|
|
[3H]WEB 2086
|
|
2-APB
|
|
2-aminoethoxydiphenylborane,
2-aminoethoxydiphenyl borate
|
|
aplaviroc
|
|
AK 602,
AK-602,
GW873140,
GW 873140,
ONO 4128
|
|
3-APMPA
|
|
(3-aminopropyl)-methylphosphinic acid,
3-aminopropyl-methyl-phosphinic acid,
3-aminopropyl(methyl)phosphinic acid,
3-amino-propyl-(P-methyl)-phosphinic acid,
CGP35024,
CGP 35024,
skf-97541,
SK&F 97541,
SKF 97541,
SKF-97,541
|
|
APNEA
|
|
2-[6-[2-(4-aminophenyl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol,
N6-2-(4-Aminophenyl)ethyladenosine
|
[125I]APNEA
|
|
[3H]2-[6-[2-(4-aminophenyl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol,
[3H]N6-2-(4-Aminophenyl)ethyladenosine
|
|
apomorphine
|
|
5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinolin-10,11-diol,
(6aR)- 6-Methyl- 5,6,6a,7-tetrahydro- 4H-dibenzo [de,g] quinoline- 10,11-diol
|
|
3-APPA
|
|
3-Aminopropanephosphinic acid,
3-aminopropyl-hydroxy-oxophosphanium,
3-amino-propyl-phosphinic acid,
3-amino-propylphosphinic acid,
3-aminopropylphosphinic acid,
3-Aminopropylphosphonous acid,
CGP27492
|
|
aprepitant
|
|
5-[[(2R,3S]-2-[(1R)-1-[3,5-bis(trifluoromethyl) phenyl]ethoxy]-3-(4-fluorphenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one
|
|
AR231453
|
|
AR 231453,
AR-231,453
|
|
AR-C126313
|
|
|
|
ARC-239
|
|
2-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-4,4-dimethyl-tetralin-1,3-dione,
ARC239
|
|
AR-C67085
|
|
2-propylthio-βγ-dichloromethylene-ATP,
[[[[(2R,3S,4R,5R)-5-(6-amino-2-propylsulfanyl-purin-9-yl)-3,4-dih ydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydrox y-phosphoryl]-dichloro-methyl]phosphonic acid,
ARC67085
|
|
arecaidine propargyl ester
|
|
prop-2-ynyl 1-methyl-5,6-dihydro-2H-pyridine-3-carboxylate
|
|
aripiprazole
|
|
7-(-4(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone,
7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one,
Abilify,
Abilitat,
OPC 14597,
OPC-14597
|
|
ARL66096
|
|
2-propylthio-βγ-difluoromethylene ATP,
ARL 66096,
FPL66096
|
|
ARP100
|
|
2-([{1,1'-biphenyl}-4-ylsulfonyl]-[1-methylethoxy]amino)-N-hydroxyacetamide,
ARP 100
|
|
arpromidine
|
|
1-[3-(4-fluorophenyl)-3-pyridin-2-yl-propyl]-2-[3-(3H-imidazol-4-yl)propyl]guanidine,
ARP,
arpromidina,
arpromidinum
|
|
1-arylmethylpyrrolidin-2-yl ethanol amine
|
|
26a,
3-[[(2R)-2-[(1R)-2-[[1-(1-benzothiophen-2-yl)-2-methylpropan-2-yl]amino]-1-hydroxyethyl]pyrrolidin-1-yl]methyl]benzonitrile
|
|
AS100
|
|
N-2,3,4 dichlorophenyl)-2-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yloxy]acetamide,
N-(3,4-dichlorophenyl)-2-[[(3Z)-3-(2,6-dioxo-1,3-dipropylpurin-8-ylidene)-2-methyl-1H-pyrazol-5-yl]oxy]acetamide
|
|
AS101
|
|
[(3Z)-3-(2,6-dioxo-1,3-dipropylpurin-8-ylidene)-2-methyl-1H-pyrazol-5-yl] 2-(3,4-dimethoxyanilino)acetate,
N-(3,4-dimethoxy-phenyl)-2-5-(2,6-di-oxo-1,3-dipropyl-2,3,6,7-tetra-hydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yloxy]-acetamide
|
|
AS1269574
|
|
AS 1269574,
AS-1269574
|
|
AS1535907
|
|
AS 1535907
|
|
AS16
|
|
2-(4-benzyloxy-phenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]-acetamide,
2-(4-benzyloxyphenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-9H-purin-8-yl)-1-methyl-pyrazol-3-yl]acetamide
|
|
AS1907417
|
|
AS 1907417
|
|
AS604872
|
|
(2S)-3-([1,1-biphenyl]-4-ylsulphonyl-N-[(R)-phenyl(2-pyridinyl)-methyl]-1,3-thiazolidine-2-carboxamide
|
|
AS70
|
|
8-[2-methyl-5-[2-oxo-2(4-phenyl-piperazin-1-yl)-ethoxy]-2H-pyrazol-3-yl]-1,3-dipropyl-3,7-dihydro-purine-2,6-dione,
(8E)-8-[2-methyl-5-[2-oxo-2-(4-phenylpiperazin-1-yl)ethoxy]-1H-pyrazol-3-ylidene]-1,3-dipropylpurine-2,6-dione
|
|
AS74
|
|
N-(1,3-benzodioxol-5-yl)-2-[[(5Z)-5-(2,6-dioxo-1,3-dipropylpurin-8-ylidene)-2H-1,2-oxazol-3-yl]oxy]acetamide,
N-benzo-[1,3]-dioxol-5-yl-2[5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-isoxazol-3-yloxy]-acetamide
|
|
AS94
|
|
N-[4-(ethoxycarbonyl)phenyl]2-[5-(2,6-dioxo-1,3dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yloxy]-acetamide
|
|
AS95
|
|
4-[[2-[[(3Z)-3-(2,6-dioxo-1,3-dipropylpurin-8-ylidene)-2-methyl-1H-pyrazol-5-yl]oxy]acetyl]amino]benzoic acid
|
|
AS96
|
|
1,3-diallyl-8-[2-methyl-5-[2-oxo-2(4-phenyl-piperazin-1-yl)-ethoxy]-2H-pyrazol-3-yl]-3,7-dihydro-purine-2,6-dione
|
|
AS99
|
|
N-[3,4](dimethyl-phenyl)2-[5-(2,6-dioxo-1,3dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yloxy]-acetamide
|
|
asenapine
|
|
5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz(2,3-6,7)oxepino(4,5-c)pyrrole,
ORG-5222
|
|
ASN02563583
|
|
|
|
ASN04421891
|
|
|
|
ASN04450772
|
|
|
|
ASN04885796
|
|
ASN 04885796
|
|
ASN06917370
|
|
ASN 06917370
|
|
asoprisnil
|
|
J867
|
|
aspirin
|
|
acetylsalicylic acid
|
|
AST-487
|
|
AST 487,
NVP-AST 487
|
|
astemizole
|
|
|
|
AT-7519
|
|
AT 7519
|
|
ataciguat
|
|
|
|
ATC0065
|
|
2-N-[4-[2-[4-bromo-2-(trifluoromethoxy)phenyl]ethylamino]cyclohexyl]-4-N,4-N-dimethylquinazoline-2,4-diamine,
N(2)-[cis-4-({2-[4-bromo-2-(trifluoromethoxy)phenyl]ethyl}amino)cyclohexyl]-N(4), N(4)-dimethylquinazoline-2,4-diamine dihydrochloride
|
|
ATC0175
|
|
N-[4-[[4-(dimethylamino)quinazolin-2-yl]amino]cyclohexyl]-3,4-difluoro-benzamide,
[N-(cis-4-{[4-(dimethylamino)quinazolin-2-yl]amino}cyclohexyl)-3,4-difluorobenzamide hydrochloride],
N-(cis-4-{[4-(dimethylamino)quinazolin-2-yl]amino}cyclohexyl)-3,4-difluorobenzamide hydrochloride
|
|
atenolol
|
|
2-[4-[2-hydroxy-3-(propan-2-ylamino)-propoxy]phenyl]acetamide,
Atehexal,
Cuxanorm,
Ibinolo,
Myocord,
Normiten,
Prenormine,
Selobloc,
Tenoblock,
Tenormin
|
|
ATFMK
|
|
arachidonoyltrifluoromethylketone,
arachidonyl trifluoromethyl ketone,
arachidonyltrifluoromethyl ketone
|
|
ATL802
|
|
|
|
ATLa2
|
|
ATL analog [15-epi-16-(para-fluoro)-phenoxy-LXA4]
|
|
atopaxar
|
|
E5555,
E 5555,
ER 172594-00
|
|
atorvastatin
|
|
|
|
ATPA
|
|
(RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl)propionic acid
|
|
ATPO
|
|
(RS)-2-amino-3-(3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid
|
[35S]ATPγS
|
|
[35S]-ATPgammaS
|
[3H]ATRA
|
|
[3H]-all-trans-retinoic acid,
[3H]-ATRA
|
|
AUY954
|
|
AUY 954
|
|
AVE 0991
|
|
|
|
axitinib
|
|
AG013736,
AG 013736,
Inlyta
|
|
AZ10417808
|
|
2-([3,4-dichlorophenyl]amino)-1,4-dihydro-6-nitro-4-oxo-N-2-propenyl-8-quinazolinecarboxamide,
AZ 10417808
|
|
AZ11645373
|
|
3-[1-[4-(3-nitrophenyl)phenoxy]-4-pyridin-4-ylbutan-2-yl]-1,3-thiazolidine-2,4-dione
|
[3H]AZ11637326
|
|
(5'-(2-fluoro[3,4,5(-3)H3]phenyl)-spiro[1-azabicyclo [2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine
|
|
3-azageranylgeranyl diphosphate
|
|
|
|
azasetron
|
|
Y-25130
|
|
aza-THIP
|
|
|
|
AZD6140
|
|
|
|
AZD-1152HQPA
|
|
AZD 1152HQPA,
INH 34
|
|
azelaoyl-PAF
|
|
1-O-hexadecyl-2-O-(9-carboxyoctanoyl)-sn-glyceryl-3-phosphocholine,
azelaoyl PAF
|
[125I]8-azido-3-iodoketanserine
|
|
[125I]-8-azido-3-iodoketanserine,
[125I]-8-azido-3-iodoketanserine (photoaffinity ligand)
|
[3H]azietomidate
|
|
|
|
azimilide
|
|
|
|
AZT
|
|
3'-azido-3'-deoxythymidine,
Zidovudine
|
| |
| B |
Back to top |
|
2b-1
|
|
|
|
baclofen
|
|
|
|
(-)-baclofen
|
|
4-amino-3-(4-chlorophenyl)-butanoic acid,
Baclon,
Kemstro,
Lioresal,
p-chlorophenyl GABA,
(R)-(-)-baclofen
|
[3H](R)-(-)-baclofen
|
|
|
|
BADGE
|
|
|
|
banyu (I)
|
|
Banyu Compound 1b
|
[3H]banyu (I)
|
|
|
|
batimastat
|
|
|
|
BAY27-9955
|
|
(+)-3,5-diiospropyl-2-(1-hydroxyethyl)-6-propyl-4′-fluoro-1,1′-biphenyl,
Bay 27-9955,
BAY 27-9955
|
|
BAY 367620
|
|
(3aS,6aS)-6a-naphtalen-2-ylmethyl-5-methyliden-hexahydro-cyclopentane[c]furan-1-on,
(3aS,6aS)-6a-naphtalan-2-ylmethyl-5-methyliden-hexahyrol-cyclopenta[c]furan-1-one,
BAY 36-7620,
BAY36-7620
|
|
BAY412272
|
|
5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-pyrimidin-4-ylamine),
BAY 41-2272
|
|
Bay60-6583
|
|
2-(6-amino-3,5-dicyano-4-(4-(cyclopropylmethoxy)phenyl) pyridin-2-ylthio)acetamide
|
|
BAY607550
|
|
2-(3,4-dimethoxybenzyl)-7-{(1R)-1-[(1R)-1-hydroxyethyl]-4-phenylbutyl}-5-methylimidazo[5,1-f][1,2,4]triazin-4(3H)-one,
Bay 60-7550
|
|
BAY-73-1449
|
|
SureCN5906729
|
|
BAYK 8644
|
|
methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate
|
|
(-)-(S)-BayK8644
|
|
(-)-(S)-methyl-1,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluromethylphenyl)-pyridine-5-carboxylate
|
|
BAYu9773
|
|
6(R)-(4′-carboxyphenyl-thio)-5(S)-hydroxy-7e,11z,14z-eicosatetraenoic acid
|
|
BAY-X1005
|
|
BAY X 1005
|
|
BCH
|
|
2-aminobicyclo-[2.2.1]-heptane-2-carboxylic acid
|
|
BCTC
|
|
N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carbox-amide
|
[125I]BE-2254
|
|
2-[[2-(4-hydroxy-3-iodanylphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one,
2-{p-(4-hydroxy-3-[125I]iodophenyl)ethylaminomethyl}-tetralone,
HEAT
|
|
befetupitant
|
|
2-(3,5-bis(trifluoromethyl)phenyl)-N-(4-(2-methylphenyl)-6-(morpholin-4-yl)pyridin-3-yl)-N-methylisobutyramide,
2-[3,5-Bis(trifluoromethyl)phenyl]-N-[6-(morpholin-4-yl)-4-o-tolylpyridin-3-yl]-N-methylisobutyramide,
Benzeneacetamide, N,α,α-trimethyl-N-[4-(2-methylphenyl)-6-(4-morpholinyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)-,
Ro 67-5930
|
|
BEL
|
|
bromoenolactone,
bromoenol lactone
|
|
benserazide
|
|
Ro 4-4602,
serazide
|
|
benzamil
|
|
|
|
(5-{[4-(benzenesulfonyl)-1,2,5-oxadiazol-3-yl]oxy}-1-hydroxy-1-phosphonopentyl)phosphonic acid
|
|
|
|
1,2,3-benzenetricarboxylic acid
|
|
1,2,3-benzenetricarboxylate
|
|
4-[3-(1-benzofuran-5-yloxy)phenyl]-1-phosphonatobutane-1-sulfonate
|
|
|
|
2-[4-(1,3-benzothiazol-2-yl)phenyl]-4-methylmorpholin-2-ol
|
|
|
|
3-[4-(1,3-benzothiazol-2-yl)phenyl]-octahydropyrido[2,1-c]morpholin-3-ol
|
|
|
|
1-benzyl-APDC
|
|
1-benzyl-(2R,4R)-4-aminopyrrolidine-2,4-dicarboxylic acid
|
|
benzylcysteine
|
|
S-benzyl-L-cysteine
|
|
benzyl(2-{4-[(E)-2-phenylethenyl]phenoxy}ethyl)amine
|
|
|
|
1-benzyl-N-(4-cyclohexylphenyl)-4-hydroxy-2-oxo-2,5-dihydro-1H-pyrrole-3-carboxamide
|
|
|
|
{2-[4-(benzyloxy)phenoxy]ethyl}(2-phenylpropyl)amine
|
|
|
|
5-benzyloxytryptamine
|
|
2-(5-phenylmethoxy-1H-indol-3-yl)ethanamine
|
|
4-[3-(2-benzylphenoxy)phenyl]-1-phosphonatobutane-1-sulfonate
|
|
|
|
benzylserine
|
|
O-benzyl-L-serine
|
|
bepridil
|
|
|
|
beraprost
|
|
(+-)-(1R,2R,3aS,8bS)-2,3,3a,8b-Tetrahydro-2-hydroxy-1-((E)-(3S,4RS)-3-hydroxy-4-methyl-1-octen-6-ynyl)-1H-cyclopenta(b)benzofuran-5-butyric acid,
beraprostum,
MDL 201229,
ML 1229
|
|
bestatin
|
|
ubenimex
|
|
beta-ergocriptine
|
|
|
|
betaxolol
|
|
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)-propan-2-ol,
Betaxololum
|
|
bethanechol
|
|
2-carbamoyloxypropyl-trimethyl-azanium,
besacholine,
mechotane,
mechothane,
mecothane,
mictone,
mictrol,
myocholine,
urecholine
|
|
bexarotene
|
|
4-(1-[3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl]ethenyl) benzoic acid,
Bexarotene,
LGD1069,
Targretin
|
|
bezafibrate
|
|
|
|
BGC201531
|
|
(N-(4-[4-(5-methoxypyridin-2-yl)phenoxymethyl]-5-methylfuran-2-carbonyl)-2-methylbenzenesulphonamide
|
|
BHF-177
|
|
BHF177
|
|
(+)-BHFF
|
|
|
|
BHQ
|
|
2,5-di-t-butyl-1,4 benzohydroquinone,
2,5-DI-(TERT-BUTYL)-1,4,BENZOHYDROQUINONE
|
|
BHT920
|
|
6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo-[4,5-d]-azepine
|
|
BI-2536
|
|
BI 2536
|
|
BIBN4096BS
|
|
1-piperidinecarboxamide, N-(2-[{5-amino-1-([4-{4-pyridinyl}-1-piperazinyl]carbonyl)pentyl}amino]-1-[{3,5-dibromo-4-hydroxyphenyl}methyl]-2-oxoethyl)-4-(1,4-dihydro-2-oxo-3[2H]-quinazolinyl),
1-Piperidinecarboxamide,N-[2-[[5-amino-1-[[4-(4-pyridinyl)-1-piperazinyl]carbonyl]pentyl]amino]1[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]4(1,4-dihydro-2-oxo-3(2H)quinazolinyl)-,[R-(R*,S*)]-,
N-[(1R)-2-[[(1S)-5-amino-1-[4-(4-pyridyl)piperazine-1-carbonyl]pe ntyl]amino]-1-[(3,5-dibromo-4-hydroxy-phenyl)methyl]-2-oxo-ethyl] -4-(2-oxo-1,4-dihydroquinazolin-3-yl)piperidine-1-carboxamide,
Olcegepant
|
|
BIBO3304
|
|
(r)-N-([4-{aminocarbonylaminomethyl}-phenyl]methyl)-N2-(diphenylacetyl)-argininamide trifluoroacetate,
(R)-N-[[4-(aminocarbonylaminomethyl)-pheyl]methyl]-N2-(diphenylacetyl)-argininamide trifluoroacetate
|
|
BIBP3226
|
|
r-N2-(diphenylacetyl)-N-(4-hydroxyphenyl)methyl-argininamide,
(R)-N(2)-(diphenylacetyl)-N-[(4-hydroxyphenyl)-methyl]-argininamide
|
[3H]BIBP3226
|
|
[3H]-BIBP3226
|
|
bicalutamide
|
|
|
|
3-bicyclo[2.2.1]hept-2-yl-benzene-1,2-diol
|
|
3-norbornan-2-ylbenzene-1,2-diol
|
|
BIIB014
|
|
|
|
BIIE0246
|
|
(S)-N2-[[1[2[4[(R,S)5,11dihydro6(6h)oxodibenz[b,e]azepin11yl]1piperazinyl]2oxoethyl]cyclopentyl]acetyl]N[2-[1,2-di-hydro-3,5-(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol4yl]ethyl]-argininamid,
(s)-N2-([1-{2-(4-[(r,s)-5,11-dihydro-6(6H)-oxodibenz[b,e]azepin-11-yl]-1-piperazinyl)-2-oxoethyl}cyclopentyl]acetyl)-N-(2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl)-argininamide
|
|
bimatoprost
|
|
AGN 192024,
LS-181817,
lumigan,
(Z)-7-[(1R,2S,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenyl-pent-1-enyl]cyclopentyl]-N-ethyl-hept-5-enamide
|
|
bimatoprost (free acid form)
|
|
17-phenyl-ω-trinor-PGF2α
|
|
BIMU 1
|
|
3-ethyl-N-[(5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]-2-oxobenzimidazole-1-carboxamide
|
|
BIMU 8
|
|
|
|
binodenoson
|
|
WRC-0470
|
|
biphenylindanone A
|
|
BINA,
LS-193,571
|
|
[1,3-bis(2,4-dichlorophenyl)-2-phosphonopropan-2-yl]phosphonic acid
|
|
|
|
3-(2,2-Bis-phosphono-ethyl)-5-decyloxy-1-methyl-pyridinium
|
|
|
|
bithionol
|
|
2,2'-sulfanediylbis(4,6-dichlorophenol)
|
|
BMS 181,101
|
|
5-fluoro-3-{3-(4-(5-methoxy-pyrimidin-4-yl)-piperazin-1-yl)-propyl}-1H-indole
|
|
BMS204352
|
|
(3S)-(+)-(5-Chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indol-2-one
|
|
BMS270394
|
|
BMS 961,
R-3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8,-TETRAHYDRO-NAPHTALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID
|
|
BMS-345541
|
|
BMS 345541
|
|
BMS-387032
|
|
BMS 387032,
SNS 032,
SNS-032
|
|
BMS493
|
|
|
|
BMS614
|
|
4-[5,6-Dihydro-5,5-dimethyl-8-(quinolin -3-yl) naphthalen-2-carboxamido] benzoic Acid,
BMS,
CID445091
|
|
BMS641
|
|
3-chloro-4-[(E)-2-(5,5-dimethyl-8-phenyl-6H-naphthalen-2-yl)ethenyl]benzoic acid,
(E)-3-Chloro-4-[2-(5,6-dihydro-5,5-dimethyl-8-phenyl naphthalen-2-yl) ethen-1-yl] benzoic Acid
|
|
BMS753
|
|
4-[(1,1,3,3-tetramethyl-2-oxo-indene-5-carbonyl)amino]benzoic Acid,
4-[(2,3-Dihydro-1,1,3,3-tetramethyl-2-oxo-1H-inden-5-yl) carboxamido]benzoic Acid
|
|
BMS Compound 87b
|
|
|
|
BMS Compound 16 [PMID:23368907]
|
|
|
|
BMY-14802
|
|
1-[4-(4-fluorophenyl)-4-hydroxybutyl]-4-(5-fluoropyrimidin-2-yl)piperazine
|
|
BMY 45778
|
|
3-(4-[4,5-diphenyl-2-oxazolyl]-5-oxazolyl)phenoxyacetic acid,
[3-(4,5-diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid,
BMY45778
|
|
BMY-7378
|
|
8-(2-(4-(2-Methoxyphenyl)-1-piperazinyl)ethyl)-8-azaspiro(4.5)decane-7,9-dione,
8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4,5]decane-7,9-dione dihydrochloride,
BMY7378
|
|
BN 50739
|
|
|
|
BN-81,644
|
|
2-[(3R)-1,1-dibutyl-1H,2H,3H,4H,9H-pyrido[3,4-b]indol-3-yl]-4-phenyl-1H-imidazole,
(3R)-1,1-Dibutyl-3-(4-phenyl-1H-imidazol-2-yl)-2,3,4,9-tetrahydro-1H-β-carboline
|
|
BN-81,674
|
|
3R)-1,1-dipentyl-3-(4-phenyl-3H-imidazol-2-yl)-2,3,4,9-tetrahydropyrido[3,4-b]indole
|
|
BNTX
|
|
7-benzylidenenaltrexone,
Bntx-7
|
|
BOMA
|
|
2-[4-(1,3-benzoxazol-2-yl)-2-methoxyphenyl]acetonitrile
|
[125I]BOP
|
|
(E)-7-[(1R,4R,5R,6R)-5-[(E,3R)-3-hydroxy-4-(4-iodanylphenoxy)but-1-enyl]-7-oxabicyclo[2.2.1]heptan-6-yl]hept-5-enoic acid ,
[125I]-I-BOP
|
|
bosentan
|
|
|
|
bosutinib
|
|
SK 606,
SKI 606
|
|
BPH-252
|
|
|
|
BPH-628
|
|
BPH 628
|
|
BPH-715
|
|
BPH 715
|
|
BPH-742
|
|
|
|
4BP-TQS
|
|
4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide
|
|
BQ788
|
|
(2R)-2-[[(2R)-2-amino-3-(1-methoxycarbonylindol-3-yl)propanoyl]-[ (2S)-2-[[(2R,6S)-2,6-dimethylpiperidine-1-carbonyl]amino]-4,4-dim ethyl-pentanoyl]amino]hexanoic acid,
N-cis-2,6-dimethylpiperidinocarbonyl-L-γ-methylleucyl-D-1-methoxycarboyl-D-norleucine
|
|
BQCA
|
|
benzyl quinolone carboxylic acid
|
|
bradyzide
|
|
-[2-(2-dimethylaminoethyl-methyl-amino)ethyl]pyrrolidine-2-carboxamide,
(2S)-1-[4-(2-(benzhydrylthiocarbamoyl)hydrazinyl)-3-nitro-phenyl]sulfonyl-N
|
|
(-)-bremazocine
|
|
2-(1-Hydroxy-cyclopropylmethyl)-5-ethyl-9,9-dimethyl-2'-hydroxy-6,7-benzomorphan,
bremazocine
|
|
bretazenil
|
|
|
|
brilliant blue G
|
|
|
|
brimonidine
|
|
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine,
UK14304,
UK14,304
|
|
brivanib
|
|
BMS 540215
|
|
BRL-15572
|
|
3-[4-(3-chlorophenyl) piperazin-1-yl]-1,1,-diphenyl-2-propanol,
3-[4-(3-chlorophenyl)piperazin-1-yl]-1,1,-diphenyl-2-propanol,
BRL15572
|
|
BRL 37344
|
|
BRL37344,
(RR,SS)-(±)-4-(2?-[2-hydroxy-2-(3-chlorophenyl)ethylamino]propyl)phenoxyacetate sodium salt sesquihydrate
|
|
BRL 44408
|
|
|
|
BRL50481
|
|
5-nitro-2,N,N-trimethylbenzenesulfonamide,
Benzenesulfonamide, N,N,2-trimethyl-5-nitro-,
BRL-50481,
N,N,2-Trimethyl-5-nitrobenzenesulfonamide
|
|
BRL-54443
|
|
BRL54443
|
|
2-Br-LSD
|
|
2-Bromo-D-lysergic acid diethylamide,
2-Bromo-LSD,
2-Bromolysergic acid diethylamide,
2-Bromolysergic diethylamide,
BOL 148,
Br-LSD,
Bromolysergide
|
|
bromocresol green
|
|
|
|
bromocriptine
|
|
2-Bromo-alpha-ergokryptin,
2-Bromoergocryptine,
alpha-Bromoergocriptine,
Bromergocryptine,
Bromocriptin,
bromocryptine,
Bromoergocriptine,
CB-154
|
|
3-bromo-7NI
|
|
3-Br-7NI,
3-bromo-7-nitroindazole,
-bromo-7-nitro-1H-indazole
|
|
2-(3-bromophenyl)histamine
|
|
2-[2-(3-bromophenyl)-1H-imidazol-5-yl]ethanamine
|
|
2-[4-(4-bromophenyl)phenyl]-4-methylmorpholin-2-ol
|
|
|
|
2-[4-(4-bromophenyl)phenyl]-4-methyl-octahydro-2H-1,4-benzoxazin-2-ol
|
|
|
|
3-[4-(4-bromophenyl)phenyl]-octahydropyrido[2,1-c]morpholin-3-ol
|
|
|
|
1-(2-bromo-phenyl)-3-((4S,5S)-2,2-dimethyl-4-phenyl-[1,3]dioxan-5-yl)-urea
|
|
|
|
3-bromopyruvate
|
|
bromopyruvic acid
|
|
(+)-5-(5-bromothiophen-3-yl)-5-methyl-4-oxo-4,5-dihydro-furan-2-carboxylic acid
|
|
5-(5-bromo-3-thienyl)-5-methyl-4-oxo-furan-2-carboxylic acid
|
|
2-[4-(5-bromothiophen-2-yl)phenyl]-4-methyl-octahydro-2H-1,4-benzoxazin-2-ol
|
|
|
|
3-[4-(5-bromothiophen-2-yl)phenyl]-octahydropyrido[2,1-c]morpholin-3-ol
|
|
|
|
brucine N-oxide
|
|
|
|
BSP
|
|
bromosulfophthalein
|
[3H]BSP
|
|
bromosulfophthalein,
[3H]-BSP
|
|
BTP2
|
|
4-methy-4'-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]-1,2,3-thiadiazole-5-carboxanilide,
4-Methyl-[1,2,3]thiadiazole-5-carboxylic acid [4-(3,5-bis-trifluoromethyl-pyrazol-1-yl)-phenyl]-amide,
[N-{4-[3,5-bis(Trifluoromethyl)-1H-pyrazol-1-yl]phenyl}-4-methyl-1,2,3-thiadiazole-5-carboxamide]
|
|
BU-E 47
|
|
1-[3-(4-chlorophenyl)-3-(2-pyridyl)propyl]-3-[3-(1H-imidazol-4-yl)propyl]guanidine,
N-[3-(4-Chloro-phenyl)-3-pyridin-2-yl-propyl]-N'-[3-(1H-imidazol-4-yl)-propyl]-guanidine
|
|
bufotenine
|
|
5-HO-DMT ,
5-OH-DMT,
Bufotenin,
Cinobufotenine,
Cohoba,
Dimethylserotonin,
DM5-HT,
Mapine,
Mappin,
Mappine,
N,N-Dimethyl-5-HT,
N,N-Dimethylserotonin
|
|
bumetanide
|
|
Edemex,
Fontego,
Fordiuran,
Lixil,
Lunetoron,
PF 1593,
Ro 10-6338
|
|
bunolol
|
|
3,4-Dihydro-5-(3-(tert-butylamino)-2-hydroxy)propoxy-1(2H)-naphthalenone,
5-(2-hydroxy-3-tert-butylamino-propoxy)tetralin-1-one,
BRN 1887243,
(-)-bunolol,
Bunololo,
Bunololum,
l-Bunolol,
Levobunolol,
W-6421A
|
|
bupivacaine
|
|
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide,
Anekain,
Bloqueina,
Bupivacaina,
Bupivacainum,
cBupivacaine,
DL-Bupivacaine,
Marcaine ,
Sensorcaine,
W-7
|
|
bupranolol
|
|
1-(2-chloro-5-methyl-phenoxy)-3-(tert-butylamino)-propan-2-ol,
3-(tert-Butylamino)-1-(6-chloro-m-tolyloxy)-2-propanol,
BRN 2272923,
Bupranol,
Bupranololum,
Ophtorenin,
SK&F 16805-A
|
|
burimamide
|
|
|
|
buspirone
|
|
8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione,
Ansial,
Buspirona,
Buspironum
|
|
(+)-butaclamol
|
|
Butaclamolum
|
|
butaprost
|
|
|
|
butaprost (free acid form)
|
|
butaprost acid
|
|
{3-[4-butoxy-2-(prop-2-en-1-yl)phenoxy]propyl}(propan-2-yl)amine
|
|
|
|
5-butyl-1H-pyrazole-3-carboxylic acid
|
|
3-butyl-1H-pyrazole-5-carboxylic acid,
5-Butyl-2H-pyrazole-3-carboxylic acid
|
[11C]butylthio-TZTP
|
|
[11C]butylthio-TZTP (PET ligand)
|
|
γ-butyrolactone
|
|
1,4-Butanolide,
1-Oxacyclopentan-2-one,
2,3,4,5-Tetrahydro-2-furanone,
2-Oxolanone,
2-Oxotetrahydrofuran,
4-Butanolide,
4-Deoxytetronic acid,
4-hydroxybutyric acid lactone,
butyric acid lactone,
NIH 10540,
NSC 4592
|
|
BVT173187
|
|
BVT 173187
|
|
BW-A1433
|
|
2-Propenoic acid, 3-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenyl)-,
3-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenyl]prop-2-enoic acid
|
|
BWA868C
|
|
3-benzyl-5-(6-carboxyhexyl)-1-(2-cyclohexyl-2-hydroxyethylamino)hydantoin
|
[3H]BWA868C
|
|
(3-benzyl-5-(6-carboxyhexyl)-1-(2-cyclohexyl-2-hydroxyethyl-amino) hydantoin
|
|
BW 245C
|
|
5-(6-carboxyhexyl)-1-(3-cyclohexyl-3-hydroxypropyl)hydantoin,
7-[3-(3-cyclohexyl-3-hydroxy-propyl)-2,5-dioxo-imidazolidin-4-yl]heptanoic acid,
BW245C
|
|
BW723C86
|
|
1-(5-(2-thenyloxy)-1H-indol-3-yl)propan-2-amine,
1-[5(2-thienylmethoxy)-1H-3-indolyl]propan-2-amine hydrochloride,
α-methyl-5-(2-thienylmethoxy)-1H-indole-3-ethanamine,
BW-72386
|
|
BX 048
|
|
an active metabolite of BX 667
|
|
BX 471
|
|
BX471,
R-N-[5-chloro-2-[2-[4-[(4-fluorophenyl)methyl]-2-methyl-1-piperazinyl]-2-oxoethoxy]phenyl]urea hydrochloric acid salt
|
|
BX 667
|
|
(S)-4-({4-[1-(Ethoxycarbonyl)-1-methylethoxy]-7-methyl-2-quinolyl} Carbamoyl)-5-[4-(ethoxycarbonyl) piperazin-1-yl]-5-oxopentanoic acid
|
| |
| C |
Back to top |
|
calcipotriol
|
|
26,27-cyclo-22-ene-1α,24S-dihydroxyvitamin D3,
MC903
|
|
calhex 231
|
|
(1S,2S,1'R)-N1-(4-chlorobenzoyl)-N2-[1-(1-naphthyl)ethyl]-1,2-diaminocyclohexane,
4-chloro-N-[(1S,2S)-2-[[(1R)-1-(1-naphthyl)ethyl]amino]cyclohexyl]benzamide,
Calhex-231
|
|
calindol
|
|
(1R)-N-(1H-indol-2-ylmethyl)-1-naphthalen-1-ylethanamine,
N-(1H-indol-2-ylmethyl)-1-naphthalen-1-yl-ethanamine,
(R)-2-{1-(1-naphthyl)ethyl-aminom-ethyl}indole
|
|
camonagrel
|
|
|
|
canagliflozin
|
|
|
|
candesartan
|
|
2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl}-1H-benzimidazole-7-carboxylic acid,
2-ethoxy-1-[(2′-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]-1H-benzimidazoline-7-carboxylic acid,
CV-11974
|
|
canertinib
|
|
|
|
cangrelor
|
|
AR C67085MX,
AR-C69931MX,
ARL69931,
[dichloro-[[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]phosphonic acid
|
|
cannabinol
|
|
Cannabinol,
Cannabinolo,
Cannabinolum
|
|
capsaicin
|
|
Axsain ,
Capsaicin,
Capsidol,
Capzasin ,
(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide,
Qutenza,
Styptysat,
Transacin,
Zostrix
|
|
capsazepine
|
|
N-[2-(4-chlorophenyl)ethyl]-7,8-dihydroxy-1,3,4,5-tetrahydro-2-benzazepine-2-carbothioamide
|
|
captopril
|
|
|
|
carazolol
|
|
1-(9H-carbazol-4-yloxy)-3-(propan-2-ylamino)-propan-2-ol,
Carazololum,
Conducton,
Suacron
|
|
carbachol
|
|
2-carbamoyloxyethyl-trimethyl-azanium,
carbacholin,
carbacholine,
carbacolina,
carbamiotin,
carbochol,
carbocholin,
carbocholine,
carcholin
|
|
carbacyclin
|
|
(5Z)-5-[(3aS,4S,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid,
carboprostacyclin
|
|
carbamazepine
|
|
calepsin
|
|
carbenoxolone
|
|
|
|
carbidopa
|
|
lodosyn
|
|
carvedilol
|
|
1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-propan-2-ol,
Carvedilolum,
Coreg,
DQ 2466,
SKF 105517
|
|
casopitant
|
|
1-Piperidinecarboxamide,4-(4-acetyl-1-piperazinyl)-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methyl-, (2R,4S)-,
4-(S)-(4-Acetylpiperazin-1-yl)-2-(R)-(4-fluoro-2-methylphenyl)piperidine-1-carboxylic acid N-[1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]-N-methylamide
|
|
CAY 10471
|
|
2-[3-[(4-fluorophenyl)sulfonyl-methyl-amino]-1,2,3,4-tetrahydrocarbazol-9-yl]acetic acid,
(+)-3-([{4-fluorophenyl}sulfonyl]methylamino)-1,2,3,4-tetrahydro-9H-carbazole-9-acetic acid,
CAY10471
|
|
CBDMB
|
|
3-amino-6-chloro-5-[(4-chlorophenyl)methylamino]-N-[[2-[(2,4-dimethylphenyl)methyl]hydrazinyl]methylidene]pyrazine-2-carboxamide
|
|
CBiPES
|
|
N-[4'-cyano-biphenyl-3-yl]-N-(3-pyridinylmethyl)-ethanesulphonamide hydrochloride
|
|
CBIQ
|
|
4-chlorobenzo[f]isoquinoline
|
|
C1-BODIPY-C12
|
|
C1-Bodipy-C12
|
|
(S)-(+)-CBPG
|
|
(s)-(1)-2-(39-carboxybicycle[1.1.1]pentyl)glycine
|
|
CCP
|
|
N-cyclohexylcarbonylpentadecylamine
|
[3H]CCPA
|
|
[3H]-CCPA
|
|
CD2665
|
|
4-(6-Methoxyethoxymethoxy-7-adamantyl naphthalen-2-yl)benzoic Acid,
4-[7-(1-adamantyl)-6-(2-methoxyethoxymethoxy)naphthalen-2-yl]benzoic acid
|
|
CD3254
|
|
|
|
CD666
|
|
4-[(E)-3-hydroxy-3-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzoic acid,
(E)-4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethylnaphthalen-2-yl)-3-hydroxy propen-1-yl]benzoic Acid
|
|
CDC
|
|
cinnamyl-3,4-dihydroxy-α-cyanocinnamate
|
|
CDDO
|
|
2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid,
(4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylic acid
|
|
CDDO-Me
|
|
2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid methyl ester
|
|
CDPPB
|
|
3-cyano-N-(1,3-diphenyl-1H-[pyrazol-5-yl)benzamide,
3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide
|
|
cediranib
|
|
AZD 2171,
ZD 2171
|
|
cefadroxil
|
|
|
|
ceftriaxone
|
|
Rocephin
|
|
celecoxib
|
|
Celebra,
Celebrex ,
Celecox,
Onsenal,
Solexa
|
|
cephalexin
|
|
Cefalexin
|
|
cephradine
|
|
Cefradine
|
|
cerivastatin
|
|
|
|
cetirizine
|
|
(±) - [2- [4- [ (4-chlorophenyl)phenylmethyl] -1- piperazinyl] ethoxy]acetic acid, dihydrochloride
|
|
(R)-cetirizine
|
|
2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid,
Zirtec,
Zyrtec
|
|
(S)-cetirizine
|
|
|
|
CFTRinh-172
|
|
3-[(3-trifluoromethyl)phenyl]-5-[(4-carboxyphenyl)methylene]-2-thioxo-4-thiazolidinone
|
|
CGP 12177
|
|
4-[2-hydroxy-3-(tert-butylamino)-propoxy]-1,3-dihydrobenzoimidazol-2-one,
(-)-4-(3-tertiarybutylamino-2-hydroxypropoxy)benzimidazol-2-one,
(−)-4-(3-tert-butylamino-2-hydroxypropoxy)-benzimidazol-2-one,
CGP12177,
(-)-CGP 12177,
CGP12177A,
CGP 12177A
|
|
CGP 35348
|
|
3-aminopropyl-(diethoxymethyl)phosphinic acid,
CGP35348,
p-(3-aminopropyl)-P-diethoxymethylphosphinic acid,
P-(3-Aminopropyl)-P-diethoxymethylphosphinic acid
|
|
CGP 36742
|
|
3-aminopropyl-butyl-phosphinic acid
|
|
CGP37849
|
|
(RS)-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid
|
|
CGP 44532
|
|
(2S)-3-[[(1S)-1-(3,4-Dichlorophenyl)ethyl]amino-2-hydro xypropyl](phenylmethyl)phosphinic acid,
3-amino-2-hydroxypropylmethylphosphinic acid,
benzyl-[(2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino]-2-hydroxy-propyl]phosphinic acid,
CGP44532
|
|
CGP 46381
|
|
3-aminopropyl-(cyclohexylmethyl)phosphinic acid
|
|
CGP 47656
|
|
3-aminopropyl-(difluoromethyl)phosphinic acid
|
|
CGP53353
|
|
5,6-bis([4-fluorophenyl]amino)-2H-isoindole-1,3-dione
|
|
CGP 55845
|
|
3-[-1-(S)-(3,4-dichlorphenyl)-ethyl]amino-2(S)-hydroxypropyl-(P-benzyl)-phosphinic acid,
CGP55845,
CGP 55845A
|
|
CGP61594
|
|
CGP 61594,
(±)-trans-4-[2-(4-azidophenyl)-acetylamino]-5,7-dichloro-1,2,3,4-tetrahydro-quinoline-2-carboxylic acid
|
|
CGP 62349
|
|
3-[1-(R)-[[2(S)-hydroxy-3-[hydroxy[(4-methoxyphenylmethyl)]phosphinyl]propyl]amino]-ethyl]-benzoic acid,
[3-[1-R-[[3-(methoxyphenylmethyl)hydroxyphosphinyl]-2(5)-hydroxypropyl]amino]ethyl]-benzoic acid,
CGP62349
|
|
CGP 64213
|
|
3-[(1R)-1-[[(2S)-2-hydroxy-3-[hydroxy-[5-[3-(4-hydroxy-3-iodophenyl)propanoylamino]pentyl]phosphoryl]propyl]amino]ethyl]benzoic acid,
[3-[-(R)-[[3-5N-[1-[2-[[3-iodo-4-hydroxyphenyl]ethyl]carboxamido]pentyl]hydroxyphosphinyl]-2(S)-hydroxy-propyl]amino]ethyl-benzoic acid,
CGP64213
|
|
CGP 71872
|
|
3-[(1R)-1-[[(2S)-3-[5-[(4-azido-2-hydroxy-5-iodobenzoyl)amino]pentyl-hydroxyphosphoryl]-2-hydroxypropyl]amino]ethyl]benzoic acid,
3-(1-(R)-(3-((5-(4-azido-2-hydroxy-5-iodobenzoylamino)pentyl)hydroxyphosphoryl)-2-(S)-hydroxypropylamino)ethyl)benzoic acid,
CGP71872
|
|
CGP7930
|
|
2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol
|
[125I]CGP 64213
|
|
3-[(1R)-1-[[(2S)-2-hydroxy-3-[hydroxy-[5-[3-(4-hydroxy-3-iodophenyl)propanoylamino]pentyl]phosphoryl]propyl]amino]ethyl]benzoic acid,
[125I]CGP64213
|
[125I]CGP 71872
|
|
3-[(1R)-1-[[(2S)-3-[5-[(4-azido-2-hydroxy-5-iodobenzoyl)amino]pentyl-hydroxyphosphoryl]-2-hydroxypropyl]amino]ethyl]benzoic acid,
CGP 71872,
[125I]CGP71872
|
[3H]CGP12177
|
|
(-)-4-(3-tert-butylamino-2-hydroxypropoxy)-benzimidazol-2-one,
[3H]-CGP12177,
[3H]CGP 12177
|
[3H](-)CGP 12177
|
|
|
[3H]CGP27492
|
|
[3H]-3-APPA,
[3H]3-APPA,
[3H]-CGP27492
|
[3H]CGP39653
|
|
(RS)-(E)-2-amino-4-propyl-5-phosphono-3-pentenoic acid
|
[3H]CGP 54626
|
|
cyclohexylmethyl-[(2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino]-2-hydroxypropyl]phosphinic acid,
[3H]CGP54626
|
[3H]CGP61594
|
|
(±)-trans-4-[2-(4-azidophenyl)-acetylamino]-5,7-dichloro-1,2,3,4-tetrahydro-quinoline-2-carboxylic acid
|
[3H]CGP 62349
|
|
[3-[1-R-[[3-(methoxyphenylmethyl)hydroxyphosphinyl]-2(5)-hydroxypropyl]amino]ethyl]-benzoic acid,
[3H]CGP62349,
[3H]-CGP 62349
|
|
CGP 20712A
|
|
2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenoxy]-propyl]amino]ethoxy]benzamide,
Cgp 20712
|
|
CGP 54626A
|
|
CGP54626,
CGP 54626,
cyclohexylmethyl-[(2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino]-2-hydroxy-propyl]phosphinic acid,
[S-(R,R)]-[3-[[1-(3,4-dichlorophenyl)ethyl]amino]-2-hydroxypropyl](cyclohexylmethyl)phosphinic acid,
[S-(R*,R*)]-[3-[[1-(3,4-Dichlorophenyl)ethyl]amino]-2-h ydroxypropyl](cyclohexylmethyl) phosphinic acid
|
|
CGP 56999A
|
|
3-[(1R)-1-[[(2S)-3-[cyclohexylmethyl(hydroxy)phosphoryl]-2-hydroxypropyl]amino]ethyl]benzoic acid
|
|
CGP 71683A
|
|
Naphthalene-1-sulfonic acid {4-[(4-amino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-amide,
trans-naphtalene-1-sulphonic acid [4-[(4-amino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl]-amide hydrochloride
|
|
CGS-12066
|
|
4-(4-Methyl-1-piperazinyl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline,
7-Trifluoromethyl-4-4-methyl-1-piperazinyl;pyrrolo[1,2-a]quinoxaline,
7-Trifluoromethyl-4-(4-methyl-1-piperazinyl)pyrrolol(1,2-a)quinoxaline,
CGS-12066A,
CGS 12066B,
CGS-12066B
|
|
CGS 15943
|
|
5-amino-9-chloro-2-(2-furyl)1,2,4-triazolo[1,5-c]quinazoline,
9-Chloro-2-(2-furanyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-amine,
CGS15943,
CGS 15943A
|
|
CGS19755
|
|
(±)-cis-4-phosphonomethylpiperidine-2-carboxylic acid,
selfotel
|
|
CGS 21680
|
|
2-(4-[2-carboxyethyl]-phenethylamino)adenosine-5'-N-ethyluronamide,
3-[4-[2-[[6-amino-9-[5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]-purin-2-yl]amino]ethyl]phenyl]propanoic acid,
CGS21680
|
|
CGS 24012
|
|
2-[6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)-ethyl]aminopurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol,
DPMA,
N(6)-(2-(3,5-Dimethoxyphenyl)-2-(2-methylphenyl)ethyl)adenosine
|
[3H]CGS19755
|
|
(±)-cis-4-phosphonomethylpiperidine-2-carboxylic acid
|
[3H]CGS 21680
|
|
[3H]3-[4-[2-[[6-amino-9-[5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]-purin-2-yl]amino]ethyl]phenyl]propanoic acid,
[3H]-CGS21680
|
[3H]CGS23131
|
|
[3H]CGS 23131,
LY223982,
[3H]-CGS23131
|
[3H]CGS8216
|
|
|
|
chenodeoxycholyl-Nε-nitrobenzoxadiazol-lysine
|
|
|
|
CHIR-258
|
|
CHIR 258,
Dovitinib lactate,
TKI 258,
TKI-258
|
|
CHIR-265
|
|
CHIR 265,
RAF 265,
RAF-265
|
|
chlordane
|
|
Chlordan,
Chlorindan
|
|
chlordiazepoxide
|
|
|
|
chlorobenzylidene malononitrile
|
|
|
|
(5-chloro-1H-benzimidazol-2-yl)(4-methylpiperazin-1-yl)methanone
|
|
(5-Chloro-1H-benzoimidazol-2-yl)-(4-methyl-piperazin-1-yl)-methanone,
methanone, (5-chloro-1H-benzimidazol-2-yl)(4-methyl-1-piperazinyl)-
|
|
2-(3-chlorophenyl)histamine
|
|
2-[2-(3-Chloro-phenyl)-1H-imidazol-4-yl]-ethylamine
|
|
(S)-2-(4-chlorophenyl)-N-(5-fluorothiazol-2-yl)-3-methylbutanamide
|
|
|
|
chloroquine
|
|
chloraquine,
chlorochine
|
|
chlorothiazide
|
|
Diuril
|
|
2-{4-[5-(3-Chloro-4-trifluoromethoxyphenyl)-[1,3,4]oxadiazol-2-yl]butyl}-[1,8]naphthyridine
|
|
7e
|
|
3-chlorotyrosine
|
|
|
|
(-)-chlorpheniramine
|
|
|
|
(+)-chlorpheniramine
|
|
3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-yl-propan-1-amine,
chlorphenamine
|
|
chlorpromazine
|
|
3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine,
Chlorderazin,
Chloropromazine,
Contomin,
Cromedazine,
Largactil,
Megaphen,
Plegomazin,
Propaphenin,
Thorazine
|
|
chlorzoxazone
|
|
|
|
CHPG
|
|
2-amino-2-(2-chloro-5-hydroxy-phenyl)acetic acid,
2-chloro-5-hydroxyphenylglycine,
(R,S)-2-chloro-5-hydroxyphenylglycine
|
|
(S)-4C3HPG
|
|
4-[(R)-amino-carboxy-methyl]-2-hydroxy-benzoic acid
|
|
chroman 28
|
|
3-(2-naphthylsulfonylamino)-3-phenyl-N-[7-(1-piperidylmethyl)chroman-4-yl]propanamide,
(R)-3-(naphthalene-7-sulfonamido)-3-phenyl-N-((R)-7-(piperidin-1-ylmethyl)-3,4-dihydro-2H-chromen-4-yl)propanamide,
(R)-3-(naphthalene-7-sulfonamido)-3-phenyl-N-((R)-7-(piperidin-1-ylmethyl)chroman-4-yl)propanamide
|
|
chromanol 293B
|
|
LS-185874,
N-[(3R,4S)-6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-N-methylethanesulfonamide
|
|
CI-1015
|
|
tricyclo[3.3.1.13,7]dec-2-yl[1S-[1α(S*)2β]-[2-[(2-hydroxycyclohexyl)amino]-1-(1H-indol-3-ylmethyl)-1-methyl-2-oxoethyl]carbamate
|
|
CI-1040
|
|
CI 1040,
PD 184352
|
|
CI-966
|
|
[1-[2-[bis-4(trifluromethyl)phenyl]methoxy]ethyl]-1,2,5,6-tetrahydro-3-pyridinecarboxylic acid
|
|
CI-988
|
|
4-{[2-[[3-(lH-indol-3-yl)-2-methyl-1-oxo-2-[[(tricyclo[3.3.1.13.7]dec-2-yloxy)carbonyl]amino]propyl]amino]-l-phenylethyl]amino}-4-oxo-[R-(R*,R*)]-butanoate N-methyl-D-glucamine,
PD-134308
|
[3H]CI977
|
|
[3H]-CI977,
[3H]-enadoline
|
|
cicaprost
|
|
13,14-Didehydro-16,20-dimethyl-3-oxa-18,18,19,19-tetradehydro-6-carbaprostaglandin I2,
2-[(2E)-2-[(3aS,4S,5R,6aS)-5-hydroxy-4-[(3S,4S)-3-hydroxy-4-methyl-nona-1,6-diynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]ethoxy]acetic acid,
Cicaprost,
Cicaprostum,
ZK 96480
|
|
cicloprolol
|
|
1-[4-[2-(cyclopropylmethoxy)ethoxy]phenoxy]-3-propan-2-ylamino-propan-2-ol,
Cicloprololum,
SL 75-177-10
|
|
CID1172084
|
|
CID 1172084
|
|
CID1792197
|
|
CID 1792197
|
|
CID2440433
|
|
CID 2440433
|
|
ciglitazone
|
|
|
|
cilansetron
|
|
|
|
cilastatin
|
|
|
|
cilobradine
|
|
1,3,4,5-Tetrahydro-7,8-dimethoxy-3-((1-(2-(3,4-dimethoxyphenyl)ethyl)-3-piperidinyl)methyl)-2H-3-benzazepin-2-one hydrochloride,
DK-AH269
|
|
cilostamide
|
|
OPC 3689
|
|
cimetidine
|
|
Cimetag,
Cimetidina,
Cimetidinum,
Eureceptor,
Gastrobitan,
Tagamet
|
|
cinacalcet
|
|
|
|
cinaciguat
|
|
BAY 58-2667
|
|
cinnamaldehyde
|
|
(E)-3-phenylprop-2-enal
|
|
cinnamic acid
|
|
|
|
ciprofibrate
|
|
|
|
ciproxifan
|
|
cyclopropyl-[4-[3-(1H-imidazol-5-yl)propoxy]phenyl]methanone
|
|
cirazoline
|
|
2-[(2-cyclopropylphenoxy)methyl]-4,5-dihydro-1H-imidazole
|
|
cis-3-ACPBPA
|
|
3-amino-cyclopentenylbutylphosphonic acid
|
|
cisapride
|
|
4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidyl]-2-methoxy-benzamide,
Acenalin,
Acpulsif,
Alimix,
Alipride,
Cisapron,
Enteropride,
Prepulsid,
Propulsid,
Propulsin
|
|
(±)-cis-2-CAMP
|
|
(±)-cis-2-aminomethylcyclopropane carboxylic acid
|
[3H](+)-cis-diltiazem
|
|
[3H]-(+)-cis-diltiazem
|
|
cis flupentixol
|
|
2-[4-[(3Z)-3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol,
alpha-flupenthixol,
cis flupenthixol,
flupenthixol
|
|
(+)-cis-H2-PAT
|
|
(+)-cis-1-phenyl-3-N,N-dimethylamino-1,2,3,4-tetrahydronaphthalene
|
|
(±)-cis-H2-PAT
|
|
1-phenyl-3-dimethylamino-1,2,3,4-tetrahydronaphthalene,
(-)-cis-1-phenyl-3-N,N-dimethylamino-1,2,3,4-tetrahydronaphthalene,
(-)-cis-H2-PAT,
(-)-cis-phenyl-3-N,N-dimethylamino-1,2,3,4-tetrahydronaphthalene
|
[3H]9-cis-retinoic acid
|
|
[3H]-9-cis-retinoic acid
|
[3H]citalopram
|
|
[3H]-citalopram
|
|
CITCO
|
|
6-(4-chlorophenyl) imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime
|
|
CJ-023423
|
|
2-Ethyl-4,6-dimethyl-1-[4-[2-[[[[(4-methylphenyl)sulfonyl]amino]carbonyl]amino]ethyl]phenyl]-1H-imidazo[4,5-c]pyridine,
Benzenesulfonamide, N-[[[2-[4-(2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]amino]carbonyl]-4-methyl-,
CJ 023423,
N-[[[2-[4-(2-Ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]amino]carbonyl]-4-methylbenzenesulfonamide,
RQ-00000007
|
|
CJ-042794
|
|
ANW-61958,
Benzoic acid, 4-[(1S)-1-[[5-chloro-2-(4-fluorophenoxy)benzoyl]amino]ethyl]-,
CJ 42794,
SureCN691577
|
|
CJ13610
|
|
1-carboxamido-1-(3-S-[4-{2-methylimididazole}-thiophenyl])-4-cyclopentylether,
CJ-13610,
CJ-13,610
|
|
CL316243
|
|
CL316,243,
disodium (R,R)-5-(2-[{2-(3-chlorophenyl)-2-hydroxyethyl}-amino]propyl)-1,3-benzodioxole-2,2,dicarboxylate
|
|
CL82198
|
|
CL 82198,
CL-82198,
N-(4-[4-morpholinyl]butyl)-2-benzofurancarboxamide hydrochloride
|
|
cladribine
|
|
|
|
2-ClATP
|
|
2-Chloroadenosine-5-triphosphate,
2-Chloro-ATP
|
|
Cl-IB-MECA
|
|
2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide,
2Cl-IB-MECA,
(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyl-tetrahydrofuran-2-carboxamide
|
|
clidinium
|
|
3-Hydroxy-1-methylquinuclidinium bromide benzilate
|
|
6-Cl-MLT
|
|
6-Cl-melatonin,
N-[2-(6-chloro-5-methoxy-1H-indol-3-yl)ethyl]acetamide
|
|
clobenpropit
|
|
N'-[(4-chlorophenyl)methyl]-1-[3-(3H-imidazol-4-yl)propylsulfanyl]methanimidamide,
Vuf 9153,
VUF 9153,
VUF-9153
|
|
clofibrate
|
|
ethyl 2-(4-chlorophenoxy)-2-methylpropanoate
|
|
clofilium
|
|
4-(4-Chlorophenyl)butyl-diethyl-heptylammonium
|
|
clomiphene
|
|
clomifene
|
|
clomipramine
|
|
3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine,
Anafranil
|
|
clonidine
|
|
Adesipress,
Catapresan,
Catapres-TTS,
Catarpres,
Catarpresan,
Catarpres-TTS,
Chlornidinum,
Clonidin,
Duraclon,
N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
|
|
cloprostenol
|
|
ICI 80996,
(Z)-7-[(1R,2S,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxy-but-1-enyl]-3,5-dihydroxy-cyclopentyl]hept-5-enoic acid
|
|
clotrimazole
|
|
|
|
clozapine
|
|
Asaleptin,
Clorazil,
Clozapin,
Clozaril,
Fazaclo,
Iprox,
Leponex,
Lepotex
|
|
CMPD-1
|
|
5-[(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-N-(2,4,6-trimethoxyphenyl)-2-furamide,
Furan-1
|
|
4-CMTB
|
|
4-chloro-α-(1-methylethyl)-N-2-thiazolylbenzeneacetamide
|
|
CNQX
|
|
2,3-Dioxo-7-nitro-1,2,3,4-tetrahydroquinoxaline-6-carbonitrile,
6-Cyano-2,3-dihydroxy-7-nitroquinoxaline,
6-cyano-7-nitroquinoxaline-2,3-dione,
6-Cyano-7-nitroquinoxaline-2,3-dione,
FG 9065
|
[3H]CNQX
|
|
6-cyano-7-nitroquinoxaline-2,3-dione
|
|
codeine
|
|
codicept,
methylmorphine
|
|
colchicine
|
|
|
|
compound 11
|
|
2-{(2R)-1-[(3,4-dichlorophenyl)sulfo nyl]-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl}-N-{2-[4-(4,5-dihy dro-1H-imidazol-2-yl)phenyl]ethyl}acetamide
|
|
compound 12
|
|
1-(5-cyclohexyl-2-oxo-1-propyl-3H-1,4-benzodiazepin-3-yl)-3-[4-(4-pyridin-3-ylpiperazin-1-yl)phenyl]urea
|
|
compound 17
|
|
6-(4-chlorophenyl)-3-[6-(1-piperidylmethyl)-2-naphthyl]thieno[2,3-e]pyrimidin-4-one,
6-(4-Chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one
|
|
compound 21
|
|
|
|
compound 23
|
|
|
|
compound 3
|
|
|
|
compound 36
|
|
|
|
compound 58
|
|
|
|
compound (+)17a
|
|
|
|
compound 29a
|
|
|
|
compound 3a
|
|
|
|
compound 20f
|
|
|
|
compound 8f
|
|
|
|
compound 2g
|
|
|
|
compound 8g
|
|
|
|
compound (S)-3h [PMID:15686947]
|
|
2-[(2R)-3-[(2S)-2-benzylpyrrolidin-1-yl]-2-hydroxypropoxy]-6-chlorobenzonitrile,
2-[3-(2-benzylpyrrolidin-1-yl)-2-hydroxy-propoxy]-6-chloro-benzonitrile (S),
2-benzylpyrridine-substituted aryloxypropanol analogue
|
|
compound 36j
|
|
|
|
compound 3j
|
|
|
|
compound 1 (Jiang et al, 2010)
|
|
4H-cyclohepta[b]thiophene-3-carboxylic acid, 2-[(2-furanylcarbonyl)amino]-5,6,7,8-tetrahydro-, ethyl ester,
BAS 00486818,
oprea1_405733
|
|
compound 9n
|
|
|
|
compound 6o
|
|
|
|
compound 2 [PMID:19230660]
|
|
(10S)-4-(cycloheptylamino)-15-(4-methyl-1,4-diazepane-1-carbonyl)-10-(propan-2-yl)-8,11,18-triazatetracyclo[9.7.0.0^{2,7}.0^{12,17}]octadeca-1(18),2(7),3,5,12,14,16-heptaen-9-one
|
|
compound 42 [PMID:22420767]
|
|
|
|
compound 42 [PMID:22545772]
|
|
|
|
compound 43 [PMID:23160941]
|
|
|
|
compound 1q
|
|
|
|
conivaptan
|
|
4′-[(2-methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepin-6-yl) carbonyl]-2-phenylbenzanilide monohydrochloride,
4'-[(2-methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepin-6-yl)-carbonyl]-2-phenylbenzanilide monohydrochloride,
vaprisol,
YM087,
YM 087
|
|
COOH
|
|
LS-191838
|
|
coolact P
|
|
(-)-isopulegol
|
|
cooling agent 10
|
|
(-)-menthoxypropane-1,2-diol
|
|
cordycepin
|
|
3'-deoxyadenosine
|
|
CP101606
|
|
(1S,2S)-1-4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol
|
|
CP105696
|
|
(+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxy-chroman-7-yl]cyclopentane carboxylic acid,
CP 105696,
CP-105,696
|
|
CP-122288
|
|
N-methyl-1-[3-[(1-methylpyrrolidin-2-yl)methyl]-1H-indol-5-yl]-methanesulfonamide
|
|
CP 154,526
|
|
butyl-ethyl-(2,5-dimethyl-7-[2,4,6-trimethylphenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amine,
CP154526,
CP154,526
|
|
CP-226269
|
|
5-fluoro-2-[[4-(2-pyridinyl)-1-piperazinyl]methyl]-1H-indole,
5-fluoro-2-[[4-(2-pyridyl)piperazin-1-yl]methyl]-1H-indole
|
|
CP-293019
|
|
7-[(4-fluorophenoxy)methyl]-2-(5-fluoro-2-pyrimidinyl) octahydro-97R,9aS)-2H-pyrido[1,2-a] pyrazine,
(7R,9aS)-7-[(4-fluorophenoxy)methyl]-2-(5-fluoropyrimidin-2-yl)-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine
|
|
CP-294838
|
|
|
|
CP-339818
|
|
1-benzyl-N-pentyl-quinolin-4-imine
|
|
CP376395
|
|
CP 376395
|
|
CP-481,715
|
|
CP481715,
CP 481715,
quinoxaline-2-carboxylic acid [4(R)-carbamoyl-1(S)-(3-fluorobenzyl)-2(S)-7-dihydroxy-7-methyloctyl]amide
|
|
CP-533536
|
|
3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid,
4-{(1S)-1-[({5-chloro-2-[(4-fluorophenyl)oxy]phenyl}carbonyl)amino]ethyl} benzoic acid, CP533536, N-(4-t-butylbenzyl)-pyridyl-3-yl-sulphonamidomethylphenoxyacetic acid,
CJ042794,
CP533536,
Evatanepag
|
|
CP-544326
|
|
Acetic acid, 2-[3-[[[[4-(1H-pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]phenoxy]-,
CP 544326,
PF 04217329,
taprenepag
|
|
CP55,244
|
|
CP 55244
|
|
CP55,667
|
|
|
|
CP55940
|
|
(1R,3R,4R)-3-[2-hydroxy-4-(1,1-dimethylheptyl) phenyl]-4-(3-hydroxypropyl)cyclohexan-1-ol,
(-)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-(3-hydroxypropyl)cyclohexan-1-ol,
(-)-3-[2-hydroxyl-4-(1,1-dimethylheptyl)phenyl]-4-[3-hydroxylpropyl]cyclohexan-1-ol,
CP55,940
|
|
CP608,039
|
|
|
|
CP734432
|
|
5-{3-[(2S)-2-{(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenyl]butyl}-5-oxopyrrolidin-1-yl]propyl}thiophene-2-carboxylate
|
|
CP 93129
|
|
7-(1,2,3,6-tetrahydropyridin-4-yl)-5,9-diazabicyclo[4.3.0]nona-2,7,10-trien-4-one
|
|
CP94253
|
|
3-(1,2,5,6-tetrahydro-4-pyridyl)-5-propoxypyrrolo[3, 2-b] pyridine,
CP-94,253
|
|
CP 99994
|
|
(+)-(2S,3S)-3-(2-methoxybenzylamino)-2-phenylpiperidine,
3-(2-methoxybenzylamino)-2-phenylpiperidine,
CP99994
|
[3H]CP55940
|
|
|
|
CPCCOEt
|
|
7-(hydroxyimino)cyclo-propa[b]chromen-1a-carboxylate ethyl ester,
cyclopropan[b]chromen-1a-carboxylate,
ethyl (7E)-7-hydroxyimino-1,7a-dihydrocyclopropa[b]chromene-1a-carboxylate
|
|
Cpd B [PMID:18477808]
|
|
3-chloro-5-trifluoromethyl-pyridin-2-yl-methoxy(4-(3-methylphenyl)methyl-1, 3-thiazolidinedione-2, 4-dione,
Cpd-B
|
|
CPFPX
|
|
|
|
(S)-4CPG
|
|
4-(1-amino-2-hydroxy-2-oxo-ethyl)benzoic acid,
4-(amino-carboxy-methyl)benzoic acid,
(S)-4-Carboxyphenylglycine,
(S)-4CPG,
(S)-4-Carboxyphenylglycine
|
[3H]CPP
|
|
(R)-3-(2-carboxypiperazine-4-yl)propyl-1-phosphonic acid
|
|
CPPG
|
|
2-[cyclopropyl-(4-phosphonophenyl)amino]acetic acid,
α-cyclopropyl-4-phosphonophenylglycine,
cyclopropyl-4-phosphonophenylglycine
|
|
CPPHA
|
|
N-[4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl]-2-hydroxybenzamide,
N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide,
N-{4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide
|
|
CPT
|
|
8-cyclopentyl-1,3-dimethyl-7H-purine-2,6-dione,
8-cyclopentyltheophylline
|
|
CPX
|
|
1,3-dipropyl-7H-purine-2,6-dione,
1,3-dipropylxanthine,
1-methyl-3-butylxanthine,
3-butyl-1-methyl-7H-purine-2,6-dione
|
|
CRA1000
|
|
2-(N-[2-methylthio-4-isopropylphenyl]-N-ethyl-amino-4-[4-{3-fluorophenyl}-1,2,3,6-tetrahydropyridin-1-yl]-6-methylpyrimidine),
CRA 1000
|
|
crizotinib
|
|
xalkori
|
|
cromakalim
|
|
3-Hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-6-chromanecarbonitrile,
Cromakalin,
Levcromakalim
|
|
CSC
|
|
|
|
5-CT
|
|
3-(2-aminoethyl)-1H-indole-5-carboxamide,
5-carboxamidotryptamine,
5-Carboxamidotryptamine
|
[3H]5-CT
|
|
[3-(2-aminoethyl)-1H-indol-5-yl]urea,
5-carbamidotryptamine-tritiated ,
[3H]5-carboxamidotryptamine
|
|
CTA2
|
|
9α,11α,11a-dicarba-TXA2,
CTA-2,
(Z)-7-[(2R,3S)-3-[(E,3S)-3-hydroxyoct-1-enyl]norpinan-2-yl]hept-5-enoic acid
|
|
CV-1674
|
|
2-(4-methoxyphenyl)adenosine,
2-[6-amino-2-(4-methoxyphenyl)-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol,
2-(p-methoxyphenyl)adenosine,
CV 1674,
NSC 310669
|
|
CV-1808
|
|
2-(6-amino-2-anilino-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol,
2-Phenylaminoadenosine
|
|
CV-6209
|
|
CV6209,
CV 6209 Chloride
|
|
CVT-6883
|
|
|
|
CX516
|
|
1-(quinoxalin-6-yl-carbonyl)piperidine,
BDP-12
|
|
CX546
|
|
1-(1,4-benzodioxan-6-ylcarbonyl)piperidine
|
|
cyamemazine
|
|
10-(3-dimethylamino-2-methyl-propyl)phenothiazine-2-carbonitrile,
Cyamepromazine
|
|
5-(4-cyano-3-methylphenyl)-2-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)nicotinitrile
|
|
compound 2
|
|
cyanopindolol
|
|
4-[2-hydroxy-3-(tert-butylamino)-propoxy]-1H-indole-2-carbonitrile
|
|
cyclacillin
|
|
|
|
(-)-cyclazocine
|
|
ciclazocina,
cyclazocine,
cyclazocinum
|
|
(+)-cyclazosin
|
|
[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)-2,3,4a,5,6,7,8,8a-octahydroquinoxalin-1-yl]-(2-furyl)methanone
|
|
cyclocreatine
|
|
1-carboxymethyl-2-iminoimidazolidine,
2-Imino-1-imidazolidineacetic acid,
AM 285
|
|
cycloheximide
|
|
CHX,
FT 3422-2,
LDN 97549,
naramycin,
NM-MCD 80,
NSC 185
|
|
cyclohexylmethyl-(1-p-tolyl-1H-indol-3-ylmethyl)-amine
|
|
Indole compound 1a
|
|
cyclopentyladenosine
|
|
2-(6-cyclopentylaminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol,
CPA,
N(6)-cyclopentyladenosine,
N6-cyclopentyladenosine
|
|
cyclothiazide
|
|
|
|
CYM5181
|
|
|
|
CYM-5442
|
|
CYM5442
|
|
CyPPA
|
|
cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine
|
|
cyproheptadine
|
|
Anarexol,
Cypoheptadine,
Cyproheptadiene,
cyproheptidine,
Dronactin,
Eiproheptadine,
Periactin,
Periactine,
Periactinol,
Peritol
|
|
cyproterone acetate
|
|
|
|
cytarabine
|
|
|
|
cytochalasin B
|
|
phomin
|
|
cytosporone B
|
|
dothiorelone G
|
| |
| D |
Back to top |
|
DABCO
|
|
|
|
DABCO-C16
|
|
C16-1,4-Diazabicyclo[2.2.2]octane,
TA279
|
|
dabuzalgron
|
|
R 450,
Ro-115-1240
|
|
DADLE
|
|
2-[[2-[[2-[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoylamino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid,
2-Alanyl-leucine enkephalin,
5-Leucine-2-alanine enkephalin,
DADL,
D: -Ala(2)-D: -Leu(5)-enkephalin,
leucine enkephalin-2-alanine
|
|
D-Ala-Lys-AMCA
|
|
(D)-Ala-(L)-Lys-Nε-AMCA,
D-Ala-Lys-N(epsilon)-7-amino-4-methylcoumarin-3-acetic acid
|
|
daltroban
|
|
2-[4-[2-[(4-chlorophenyl)sulfonylamino]ethyl]phenyl]acetic acid,
4-[2-[[(4-chlorophenyl)sulphonyl]amino]ethyl]benzeneacetic acid,
BM-13505,
daltrobanum,
SK&F 96148,
SKF 96148
|
|
4-DAMP
|
|
(1,1-dimethyl-3,4,5,6-tetrahydro-2H-pyridin-4-yl) 2,2-diphenylacetate,
4-Diphenylacetoxy-1,1-dimethylpiperidinium,
4-Diphenylacetoxy-N-methylpiperidine methiodide
|
|
dantrolene
|
|
|
|
D-AP4
|
|
D-2-amino-4-phosphonobutiric acid
|
|
d-AP5
|
|
5-phosphono-D-norvaline,
D-(-)-2-amino-5-phosphonopentanoic acid,
D-2-amino-5-phosphonopentanoic acid,
D-2-amino-5-phosphonovaleric acid,
D-aminophosphonovaleric acid,
D-AP-5,
(R)-2-amino-5-phosphonopentanoate
|
|
dapagliflozin
|
|
|
|
darifenacin
|
|
2-[1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenyl-acetamide
|
[3H]darifenacin
|
|
|
|
darusentan
|
|
HMR-4005,
Lu 135252,
LU135252,
LU-135252,
(+)-(S)-2-(4,6-dimethoxypyrimidin-2-yloxy)-3-methoxy-3,3-propionic acid
|
|
dasatinib
|
|
BMS 345825,
BMS 354825,
BMS 35482513,
Sprycel,
Spyrcel
|
[35S]dATPαS
|
|
[35S]-dATPαS
|
|
DAU 6285
|
|
(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)6-methoxy-2-oxo-3H-benzoimidazole-1-carboxylate hydrochloride
|
|
DAX
|
|
1,3-diallyl-8-cyclohexyl-7H-purine-2,6-dione,
1,3-diallyl-8-cyclohexylxanthine
|
|
dazoxiben
|
|
4-(2-(1H-Imidazol-1-yl)ethoxy)benzoic acid
|
|
d-CCPene
|
|
(R)-(E)-3-(2-carboxypiperazine-4-yl)propenyl-1-phosphonic acid
|
|
DCDPC
|
|
dichloro-diphenylamine 2-carboxylic acid
|
|
DC-EBIO
|
|
5,6-dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one,
5,6-dichloro-3-ethyl-1H-benzimidazol-2-one,
dichloro-EBIO
|
|
DCG-IV
|
|
(2S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl)glycine,
(2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine
|
|
(S)-3,4-DCPG
|
|
4-[(1S)-1-amino-2-hydroxy-2-oxoethyl]phthalic acid,
(S)-3,4-dicarboxyphenylglycine,
(S)-3,4-DCPG,
(S)-3,4-dicarboxylphenylglycine
|
|
DCPIB
|
|
4-(2-butyl-6,7-dichlor-2-cyclopentyl-indan-1-on-5-yl) oxybutyric acid
|
|
3-deazaadenosine
|
|
3-deaza-adenosine
|
|
decyl dihydrogen phosphate
|
|
decanol phosphate,
decyl phosphate,
FAP10,
FAP-10
|
|
{2-[3-(decyloxy)phenyl]-1-hydroxy-1-phosphonoethyl}phosphonic acid
|
|
|
|
denopamine
|
|
4-[2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxy-ethyl]phenol,
Denopamina,
Denopamine,
Denopaminum,
TA 064
|
[3H]2-deoxyglucose
|
|
2-deoxy-D-glucose,
2-DG,
[3H]-2-deoxyglucose
|
|
8-deoxy-neodysiherbaine
|
|
8-deoxy-neoDH
|
|
1-deoxynojirimycin-1-sulfonic acid
|
|
|
|
11-deoxy-PGE2
|
|
|
|
15-deoxy-Δ12,14-PGJ2
|
|
15d-Δ12,14-PGJ2,
15deoxy-delta-12,14-PGJ2,
(Z)-7-[(1S,5E)-5-[(Z)-oct-2-enylidene]-4-oxo-1-cyclopent-2-enyl]hept-5-enoic acid
|
|
DEPX
|
|
1,3-diethyl-8-phenyl-7H-purine-2,6-dione,
1,3-diethyl-8-phenylxanthine,
DPX
|
|
dequalinium chloride
|
|
|
|
desipramine
|
|
3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N-methylpropan-1-amine,
active metabolite of imipramine,
Norpramin,
Pertofrane
|
|
(-)-devapamil
|
|
4-Desmethoxyverapamil ,
4-DMV ,
(-)-D888,
(-)-Desmethoxyverapamil,
(-)-H3-Desmethoxyverapamil
|
[3H](-)devapamil
|
|
[3H](2S)-2-(3,4-dimethoxyphenyl)-5-[2-(3-methoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile
|
[3H]devazepide
|
|
[3H]-devazepide
|
|
dexamethasone
|
|
desametasone,
fluormethylprednisolone
|
[3H]dexamethasone
|
|
[3H]-dexamethasone
|
|
dexetimide
|
|
(3R)-3-(1-benzyl-4-piperidyl)-3-phenyl-piperidine-2,6-dione,
Benzetimide,
Dexbenzelimid,
Dexbenzetimid ,
Dexbenzetimide,
Serenone,
Tremblex
|
|
dexloxiglumide
|
|
CR-2017,
(R)-4-(3,4-Dichlorobenzamido)-N-(3-methoxypropyl)-N-pentylglutaramic acid
|
|
dexmedetomidine
|
|
4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole,
MPV 1440
|
|
dextroamphetamine
|
|
(+)-alpha-methylphenylethylamine,
d-amphetamine,
D-amphetamine,
D-am-phetamine,
Dextroamphetamine,
S(+)amphetamine
|
|
DFB
|
|
1-(3-fluorophenyl)-N-[(3-fluorophenyl)methyleneamino]methanimine,
3,3'-difluorobenzaldazine,
3,3'-Difluorobenzaldazine
|
|
DFMO
|
|
2-(difluoromethyl)ornithine,
α-difluoromethyl-L-ornithine,
eflornithine
|
|
DG-041
|
|
(2E)-3-[1-(2,4-Dichlorobenzyl)-5-fluoro-3-methyl-1H-indol-7-yl]-N-[(4,5-dichloro-2-thienyl)sulfonyl]acrylamide,
2-Propenamide, 3-[1-[(2,4-dichlorophenyl)methyl]-5-fluoro-3-methyl-1H-indol-7-yl]-N-[(4,5-dichloro-2-thienyl)sulfonyl]-,
DTSI
|
|
DH97
|
|
2-benzyl-N-pentanoyltryptamine
|
|
DHβE
|
|
dihydro-β-erythroidine
|
|
3,5-DHPG
|
|
2-amino-2-(3,5-dihydroxyphenyl)-acetic acid,
3,5-Dihydroxyphenylglycine,
DHPG,
S-3,5-dihydroxyphenylglycine
|
|
β-D-hydroxybutyric acid
|
|
3-D-hydroxybutyric acid,
3-hydroxybutanoic acid,
3-hydroxybutyrate,
β-D-hydroxybutyrate,
D-3-hydroxybutyric acid,
D-β-hydroxybutyrate
|
|
2,4 diahexanxoylphloroglucinol
|
|
|
|
diamide 7
|
|
|
|
diarylpropionitril
|
|
DPN
|
|
diazepam
|
|
|
|
diazoxide
|
|
7-chloro-3-methyl-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide,
Eudemine,
Hyperstat ,
Hypertonalum,
Proglicem,
Proglycem
|
|
diBA-(5)-C4
|
|
bis-(1,3-dibutylbarbituric acid)pentamethine oxanol,
oxalon dye
|
|
1-(2,4-dibromo-phenyl)-3-((4S,5S)-2,2-dimethyl-4-phenyl-[1,3]dioxan-5-yl)-urea
|
|
JNJ10397049,
JNJ-10397049
|
|
dibutyryl cAMP
|
|
Actosin,
Bucladesine,
Cyclic AMP dibutyrate,
dbcAMP,
N6-2'-O-Dibutyryl-3',5'-AMP,
N6,O2'-Dibutyrylcyclic adenosine 3',5'-phosphate,
NSC 143108
|
|
dichloroacetate
|
|
DCA,
dichloroacetic acid
|
|
3,4-dichlorobenzamil
|
|
3',4'-dichlorobenzamil
|
|
5,7-dichlorokynurenic acid
|
|
|
|
diclofenac
|
|
2-[2-(2,6-dichloroanilino)phenyl]acetic acid,
Dichlofenal,
Diclofenac acid,
Diclofenacum,
Dicrofenac ,
Novapirina,
Pennsaid
|
|
dicyclomine
|
|
2-diethylaminoethyl 1-cyclohexylcyclohexane-1-carboxylate,
dicycloverin,
dicycloverine
|
|
didanosine
|
|
dideoxyinosine,
Videx
|
|
DIDS
|
|
4,4´-diisothiocyanostilbene-2,2´-disulphonic acid
|
|
2,2-difluoromevalonate 5-diphosphate
|
|
|
|
difluorophenyl-dihydro-indenyl isobutyl-dioxopiperazinyl-isopropylethanamide
|
|
(2R)-2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)- 6-isobutyl-2,5-dioxopiperazin-1-yl]-N-isopropylethanamide
|
|
digeranyl bisphosphonate
|
|
|
[3H]dihydroalprenolol
|
|
[3H]-dihydroalprenolol
|
|
2,3-dihydro-1,4-dithiin-1,1,4,4-tetroxide
|
|
|
|
dihydroergocryptine
|
|
DHC,
Dihydroergokryptine
|
|
dihydroergotamine
|
|
Angionorm,
Dergotamine,
Dihydergot,
Dirgotarl,
Endophleban,
Ergomimet,
Ergotonin,
Migranal,
Orstanorm
|
|
dihydrokainate
|
|
|
|
13,14-dihydro-15-keto-PGD2
|
|
13,14-Dihydro-15-keto-pgd2,
13,14-dihydro-15-ketoprostaglandin D2,
13,14-Dihydro-15-keto-prostaglandin D2,
13,14-dihydro-15-oxo PGD2,
DK-PGD2,
(Z)-7-[(1R,2R,5S)-5-hydroxy-3-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid
|
|
13,14-dihydro-16-m-chlorophenoxy-w-tetranor-PGF1α
|
|
|
|
dihydromorphine
|
|
paramorphan
|
|
dihydrosphingosine-1-phosphate
|
|
dihydroS1P,
dihydrosphingosine-1-phosphate,
sphinganine 1-phosphate,
sphinganine-phosphate
|
|
3,5-dihydroxybenzoic acid
|
|
5-carboxyresorcinol,
α-resorcylic acid,
NSC 22948
|
|
7,4'-dihydroxyisoflavone
|
|
Daidzein
|
|
5,7-dihydroxy-4'-methoxyisoflavone
|
|
4'-Methylgenistein,
biochanin A
|
|
dilazep
|
|
|
|
diltiazem
|
|
(2S,3S)-(+)-cis-3-Acetoxy-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one,
(+)-cis-diltiazem,
CRD-401,
D-(cis)-diltiazem
|
|
dimaprit
|
|
3-dimethylaminopropylsulfanylmethanimidamide
|
|
9-dimethylamino-3-(4-ethylphenyl)-3H-5-thia-1,3,6-triazafluoren-4-one
|
|
|
|
1-[17-(1,5-Dimethyl-hexyl)-3-hydroxy-4,4,10,13-tetramethyl-1,2,3,4,5,6,9,10,11,12,13,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-14-yl]-ethanone
|
|
|
|
dimethylhistaprodifen
|
|
2-[2-(5,5-Diphenyl-pentyl)-1H-imidazol-4-yl]-ethylamine
|
|
4-[dimethyl(9-phenylnonyl)azaniumyl]butane-1-sulfonate
|
|
|
|
4-{dimethyl[5-(4-phenylphenyl)pentyl]azaniumyl}butane-1-sulfonate
|
|
|
|
3,5-dimethyl PPP
|
|
3,5-dimethyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-tri-methyl-propyl) ester,
3,5-DMPPP
|
|
dimethyltryptamine
|
|
2-(1H-indol-3-yl)-N,N-dimethyl-ethanamine,
DMT
|
|
dimethyl-W84
|
|
|
[3H]dimethyl-W84
|
|
N,N'-bis[3-(1,3-dihydro-1,3-dioxo-4-methyl-2H-isoindol-2-yl)propyl]-N,N,N',N'-tetramethyl-1,6-hexanediaminium diiodide
|
|
DIOA
|
|
2-[(2-butyl-6,7-dichloro-2-cyclopentyl-1-oxo-3H-inden-5-yl)oxy]acetic acid
|
|
dioctanoylglycerol pyrophosphate
|
|
DGPP,
DGPP 8:0
|
|
dioscin
|
|
|
|
diphenhydramine
|
|
2-benzhydryloxy-N,N-dimethyl-ethanamine,
alledryl,
benadryl,
benzhydramine,
dimehydrinate,
diphenylhydramine
|
|
diphenyltetrahydrofuran
|
|
|
|
1-(diphosphenyloxy)-3,4-dimethylpentan-3-ol
|
|
|
|
1-(diphosphenyloxy)-3-methylpentan-3-ol
|
|
|
|
diphosphoglycolyl proline
|
|
diphosphoglycolyproline,
DPGP,
{[(Phosphonatooxy)phosphinato]oxy}acetyl)pyrrolidine-2-carboxylate,
(R,S)-diphosphoglycolyl proline
|
|
diprenorphine
|
|
|
[3H]diprenorphine
|
|
[15,16-3H]diprenorphine
|
|
dipropyl-5-CT
|
|
3-(2-dipropylaminoethyl)-1H-indole-5-carboxamide,
DP5CT,
DP-5-CT,
N,N-dipropylcarboxamidotryptamine
|
|
dipyridamole
|
|
persantine
|
|
D-kynurenine
|
|
|
|
DL-TBOA
|
|
dl-threo-β-benzyloxyaspartate
|
|
DL-threo-β-hydroxyaspartate
|
|
|
|
DM 1451
|
|
7-{4-[4-(4-hydroxy-2,3-dimethylphenyl)piperazin-1-yl]butoxy}-1,2,3,4-tetrahydroquinolin-2-one
|
|
DMCM
|
|
methy-6,7-dimethoxy-4-ethyl-b-carboline-3-carboxylate
|
|
DMP696
|
|
4-(1,3-dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine,
DMP 696
|
|
DMPP
|
|
1,1-dimethyl-4-phenylpiperazinium
|
|
DM-PPP
|
|
3,5-dimethyl-pyrrole-2,4-dicarboxylic acid 2-propylester 4-[(S)-1,2,2-trimethylpropyl]ester
|
|
DOB
|
|
1-(2,5-dimethoxy-4-bromo-phenyl)-2-aminopropane,
2,5-dimethoxy-4-bromoamphetamine,
dimethoxy-4-bromoamphetamine hydrobromide
|
[3H](+)DOB
|
|
(+)-[3H]1-(4-bromo-2,5-dimethoxyphenil)-2-aminopropane,
4-bromo-2,5-dimethoxyphenylisopropylamine
|
|
dobutamine
|
|
4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol,
Dobutamina,
Dobutaminum,
Dobutrex,
Inotrex
|
|
4-[3-(dodeca-1,3-diyn-1-yl)oxiran-2-yl]butanoic acid
|
|
|
|
dodecane-1-hydroxy-1,1-bisphosphonate
|
|
|
|
{2-[dodecyl(methyl)amino]-1-phosphonoethyl}phosphonic acid
|
|
|
|
dodecylphosphonic acid
|
|
dodecanol phosphate,
dodecylphosphate,
FAP12,
FAP-12
|
|
dofetilide
|
|
|
|
DOI
|
|
1-(4-iodo-2,5-dimethoxy-phenyl)propan-2-amine,
2,5-Dimethoxy-4-iodoamphetamine,
2,5-Dimethoxy-4-iodophenylisopropylamine,
4-DOI,
4-Iodo-2,5-dimethoxyamphetamine,
4-Iodo-2,5-dimethoxyphenylisopropylamine
|
|
(+)-DOI
|
|
|
|
(R)-DOI
|
|
(-)-2,5-dimethoxy-4-iodoamphetamine,
(-)-DOI,
R-2-(2,5-dimethoxy-4-iodophenyl)aminoethane
|
[125I]DOI
|
|
|
|
DOM
|
|
2,5-Dimethoxy-4-Methylamphetamine,
4-Methyl-2,5-dimethoxyamphetamine,
dl-2,5-Dimethoxy-4-methylamphetamine,
dl-4-Methyl-2,5-dimethoxyamphetamine,
STP
|
|
domperidone
|
|
6-chloro-3-[1-[3-(2-oxo-3H-benzimidazol-1-yl)propyl]piperidin-4-yl]-1H-benzimidazol-2-one
|
|
donitriptan
|
|
4-[4-[2-[[3-(2-aminoethyl)-1H-indol-5-yl]oxy]acetyl]piperazin-1-yl]benzonitrile,
F 11356
|
|
doramapimod
|
|
Birb 796,
BIRB 796BS
|
|
dorsomorphin
|
|
|
|
doxepin
|
|
|
[11C]doxepin
|
|
[11C]-doxepin
|
|
DPC
|
|
Diphenylamine-2-carboxylic acid,
NPA,
N-phenylanthranilic acid
|
|
DPCPX
|
|
1,3-dipropyl-8-cyclopentylxanthine,
1,3-Dpcpx,
8-cyclopentyl-1,3-dipropyl-7H-purine-2,6-dione,
8-cyclopentyl-1,3-dipropylxanthine,
8-Cyclopentyl-1,3-dipropylxanthine
|
[3H]DPCPX
|
|
[3H]-DPCPX
|
| |